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1 The Institute – An Overview 
The Ludwig Boltzmann Institute for Health Technology Assessment (LBI-
HTA) was formally founded on March 2006 and is intended to operate for a 
period of seven years. Therefore 2008 was the 3rd year of the institute’s opera-
tional activity. On May 7 and 8 2009 there will be an evaluation regarding its 
continuation until 2013. International experts will appraise on the basis of 
explicit criteria preassigned by the Ludwig Boltzmann Society. 
1.1 Budget 
In the first two years (2006-2007) the budget of the Ludwig Boltzmann Insti-
tute for Health Technology Assessment averaged € 820.00 p.a., in 2008 it was 
increased to € 870.000. The annual budget is funded by the institutional 
partners and the Ludwig Boltzmann Society. 
Additional third party funding has been acquired through participation in 
the EU EUnetHTA project “European Network for Health Technology As-
sessment” (2006-2008), Inno-HTA (2008-2009) and through further projects 
amounting to € 120.000, which account for 14% of third-party funds.  
1.2 Partners 
In line with the research policy of the Ludwig Boltzmann Society, the insti-
tute focuses on translational research. The research programme requires 
strong emphasis on applicable short term or medium term results. By setting 
up partnerships between research-producing and research-applying organi-
sations or institutions, the quick transfer of research results is guaranteed.  
Partner-institutions of the Ludwig Boltzmann Institute for Health Technol-
ogy Assessment are actors in health care administration, responsible bodies 
of public hospitals and private universities.  
TILAK/Tiroler Landeskrankenanstalten GmbH 
Anichstraße 35, 6020 Innsbruck 
http://www.tilak.at 
KAGES/Steiermärkische Krankenanstalten GmbH 
Stiftingtalstraße 4-6, 8010 Graz 
http://www.kages.at 
 
2008: 
3rd year of existence 
evaluation in 2009 
total budget 
third-party funds 
translational research: 
partners apply results 
institutional partners 
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AUVA/Allgemeine Unfallversicherungsanstalt 
Adalbert-Stifterstraße 65, 1201 Wien  
http://www.auva.at 
BMGFJ/Bundesministerium für Gesundheit, Familie und Jugend 
Radetzkystraße 2 , 1030 Wien  
http://www.bmgfj.gv.at  
UMIT/Private Universität für Gesundheitswissenschaften, Medizi-
nische Informatik und Technik 
Institut für Public Health, Medical Decision Making und HTA 
Eduard Wallnöfer-Zentrum I, 6060 Hall  
http://www.umit.at 
PMU/Paracelsus Medizinische Privatuniversität 
Institut für Public Health  
Ignaz Harrer Straße 79, 5020 Salzburg 
http://www.pmu.ac.at 
HVB/ Hauptverband der österreichischen Sozialversicherungsträger 
(2008-2013) 
Kundmanngasse 21, 1030 Wien 
http://www.hauptverband.at 
Since 2008, for a period of five years, a further cooperational agreement has 
been negotiated with the Austrian Federation of Social and Health Insur-
ances (HVB).  
 
new partner  
since 2008: HVB 
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1.3 Committees 
The LBI-HTA is supported by two committees, namely the Board of Trus-
tees and the Scientific Advisory Group (SAG). 
Figure 1.3-1: Organigram 
Whereas the LBI-HTA’s research programme provides a general methodo-
logical background, agenda setting for current projects is the task of the 
Board of Trustees, which is composed of one representative from each insti-
tutional partner.  
 
KAGES: Dr. August Gomsi (Chair) 
TILAK: Univ. Prof. Dr. Wolfgang Buchberger 
AUVA: Univ. Prof. Dr. Hartmut Pelinka 
BMGFJ: Dr. Wolfgang Ecker 
UMIT: Univ. Prof. Dr. Uwe Siebert 
PMU: Dr. Markus Schwarz 
LBG: Mag. Claudia Lingner 
HVB: Dr. Gottfried Endel 
Board meetings 2008: 
b 1st Board meeting: 03/06/2008 
b 2nd Board meeting: 14/10/2008 
 
members of the  
Board of Trustees 
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Besides the financial report of the LBI-HTA, the first Board meeting in 
2008 also dealt with the completed scientific work programme. Afterwards, 
focal research points were discussed, concrete projects topics for the period 
2008 to 2010 were collected, prioritised and defined. 
During the second Board meeting the director reported on the 2008 budget. 
Furthermore human resources development, methodological advancement 
and the status quo of project planning for 2008+ period were discussed, fol-
lowed by a discussion on how institutional partners could contribute in this 
context.  
The Scientific Advisory Group (SAG) gives scientific support and is selected 
– with equal weighting – by the Ludwig Boltzmann Society and the members 
of the Board of Trustees. The SAG is composed of the following members: 
b Univ. Prof. Dr. Norman Waugh/UK 
b Univ. Prof. Dr. Alistair Gray/UK 
b Univ. Prof. Dr. Jürgen Windeler/D 
b Univ. Prof. Dr. Finn Borlum Kristensen/DK 
b Dr. Dagmar Lühman/D. 
The second meeting of the Scientific Advisory Group took place at the LBI-
HTA on April 30th 2008. On the one side, the meeting focused on discussing 
the scientific work programme for 2008. Furthermore, some LBI-HTA re-
searchers presented selected projects which had a high level of political im-
pact and relevance, and highlighted the need for more transparency. These 
were: 
b „Economic evaluation of vaccination against human papillomavi-
rus (HPV)  - Ingrid Zechmeister 
b „MEL/ evaluation of individual medical services for DRG- cata-
logue & CAL/ catalogue of ambulatory services: shaping the proc-
ess“  -  Claudia Wild 
On the other hand, there were also presentations about selected projects with 
a special need for intensive international cooperation: 
b „HPV vaccination“ – Ingrid Zechmeister 
b „Avastin“ - Claudia Wild 
b „Rational Vaccination Policies - Decision Support“ - Brigitte Piso 
The meeting of the Scientific Advisory Group was closed with the topic 
“Supporting the future of HTA in Austria” and a discussion of how this in-
strument could be further supported.  
 
1st board meeting 2008:  
03/06/ 
2nd board meeting 
2008: 
14/10/ 
members of the 
Scientific Advisory 
Group  
2nd meeting of the 
Scientific Advisory 
Group: 
30/04/ 
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1.4 Staff & Human Resources Development 
Besides the organisational development of an interdisciplinary research in-
stitute, professionalisation and specialisation of the team members are key 
issues. Becoming an interdisciplinary research institute involves the ex-
change of perspectives and methodologies, cooperation during projects, in-
ternal presentations and discussions and internal evaluations in order to en-
sure high quality work. 
The Ludwig Boltzmann Society has initiated regular director meetings in 
order to increase both management capacities and identity building. Fur-
thermore, Claudia Wild attended a meeting on “Humour & Leadership” on 
January 24 2008.  
All researchers took part in the following methodology development courses: 
b „Endnote“ – Course (10/03/2008), 
b „Scientific Writing in English“ (13/03/2008),  
b „RefWorks“ - Course (31/03/2008), 
b „Clinical Research – Study Protocols“ (28/10/2008)  
b „Clinical Epidemiology“ (18/-19/11/2008, 15/12/2008, 17/12/2008) 
and 
b „The Application of the GRADE tool“ (16/12/2008).  
Several researchers attended the following courses:  
b SPSS-Course, UMIT/Hall in Tirol, 12/-13/01/2008 (Bernhard 
Martin, Sabine Geiger-Gritsch, Stefan Mathis) 
b Workshop „Systematic Reviews“, German Cochrane Centre, 
Freiburg, 03/-05/04/2008 (Brigitte Piso) 
b Seminar “Methods of Modelling”, Drahtwarenhandlung, Techni-
cal University of Vienna, 21/04/2008 (Claudia Wild, Erwin Falk-
ner, Philipp Radlberger, Sabine Geiger-Gritsch, Stefan Mathis) 
b Seminar „Performance measuring in inpatient health care“, IHS - 
Institute for Advanced Studies, Vienna, 23/04/2008 (Philipp Radl-
berger) 
b HTA course “Health Technology Assessment: From Theory to Evi-
dence to Policy”, Toronto/Canada; 29/04/- 02/05/2008 (Sabine 
Geiger-Gritsch) 
b HTA course of lectures, Danube University Krems, 07/05/2008 
(Philipp Radlberger) 
b HTA course of lectures, Danube University Krems, 05/-10/05/2008 
(Falkner Erwin) 
b Seminar „Experiences in psychosomatic care“, Otto-Wagner-
Hospital, Vienna, 25/06/2008 (Roman Winkler) 
b „Vienna Healthcare Lectures: Measuring Performance and Quality 
in Health Systems”, London School of Economics, HVB, 30/06/-
04/07/2008 (Philipp Radlberger) 
b Pre-conference workshop „Introduction to HTA“, HTAi confer-
ence, 5th annual meeting, Montreal/Canada, 06/07/2008 (Roman 
Winkler) 
objectives: 
professionalisation, 
specialisation 
leadership training for 
director 
increasing 
methodological know-
how for researchers 
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b Pre-conference workshop „Horizon Scanning for Emerging Health 
Technologies“, HTAi conference, 5th annual meeting, Mont-
real/Canada, 06/07/2008 (Sabine Geiger-Gritsch) 
b HTA methods seminar series, Department for Evidence-based 
Medicine and Clinical Epidemiology, Danube University Krems, 
22/09/, 15/10/, 12/11/, 04/12/2008 (Michael Gyimesi, Roman 
Winkler) 
b Seminar „Opportunities and Limits of therapeutic Groups in Psy-
chiatry“, Otto-Wagner-Hospital, Vienna, 22/10/2008 (Roman 
Winkler) 
b Continuing education course „LKF-Model 2009 - Business Circle“, 
Vienna, 04/11/08 (Claudia Wild) 
b ISPOR pre-conference workshops “Cost Estimation and Assessing 
Budget Impact of new Health Care Technologies”, 08/11/2008, 
“Elements of Pharmaceutical Pricing – Introduction”, 08/11/2008, 
and “Reimbursement Systems in Europe”, 09/11/2008, Ath-
ens/Greek (Sabine Geiger-Gritsch) 
b Seminar „Psychotraumatology: Actual state of scientific knowl-
edge“, Otto-Wagner-Hospital, Vienna, 03/12/2008 (Roman Wink-
ler) 
On January 22 & 23 2008, all LBI-HTA members attended the „Powertalk-
ing II“ course (Part I took place on November 19 & 20 2007), which dealt 
with language patterns and communication behaviour. Furthermore, Clau-
dia Wild, Ingrid Zechmeister and Sabine Geiger-Gritsch took part in the 
„IntoMedia – Rational arguments against the force of demand” media train-
ing on February 2 2008 in Vienna. 
As a part of his doctoral studies in National Economic Policy at the Vienna 
University of Economics and Business Administration, Philipp Radlberger 
attended the classes (WS 07/08, SS 08 and WS 08/09) „Social Politics“, 
„Quantitative Research Methods“, „Scientific Theory“, „Qualitative Re-
search Methods“, „European Integration”, “European Colloquium”, „Aca-
demic Writing/Research Proposal“ and „Increase in Efficiency in small and 
medium sized health companies”.  
As part of her extra-occupational Heath Sciences Studies at the UMIT/Hall 
in Tirol, Sabine Geiger-Gritsch attended the following courses: “Public 
Health & Epidemiology” (07/-11/01/2008 & 25/-29/02/2008) and “Law in 
the Health Care System (07/-12/04/2008). In 2008 she successfully com-
pleted her Masters thesis and graduated with the academic degree of „Mas-
ter of Public Health“ (MPH). 
In the WS 08/09 Tim Johansson started his doctoral studies at the PMU/ 
Paracelsus Medical Private University in Salzburg. 
Claudia Wild’s habilitation procedure was initiated at the Medical Univer-
sity of Graz in November 2008.  
As an interdisciplinary institute the organisation of work is guided by pro-
fessional – assigned topic-specific – project management. 
 
rhetoric course &  
media training 
university education  
project management 
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Director: 
b Claudia Wild, Dr. Phil. 
Research Background: Communication Science, Psychology, Political 
Science 
Deputy Director: 
b Ingrid Zechmeister, Dr. rer.soc.oec., MA 
Research Background: Health Economics (on maternity leave since 
20/10/2008) 
Office-Assistant: 
b Smiljana Blagojevic, Dipl.-Ing. 
Assistant-to-the-director & Science Communications: 
b Gerda Hinterreiter, Mag. rer.soc.oec. (since 01/09/2008) 
Research Background: Medical Sociology, Communication 
Information Specialist: 
b  Tarquin Mittermayr, BA (Hons) (since 01/09/2008) 
Information Specialist: 
b  Beate Guba, Mag. phil., MSc (until 30/06/2008) 
Researchers: 
b Brigitte Piso, Dr. med., MPH (since 01/02/2008) 
Research Background: Medicine, Public Health 
b Erwin Falkner 
Research Background: Biology 
b Gerald Gartlehner, Dr. med., MPH (until 28/02/2008) 
Research Background: Medicine, Public Health  
b Michael Gyimesi, Dr. tech. Dipl.-Ing. (since 01/10/2008) 
Research Background: Modelling, Simulation 
b Philipp Mad, Dr. med. 
Research Background: Medicine 
b Philipp Radlberger, Mag. rer.soc.oec.  
Research Background: Health Economics 
b Rosemarie Felder-Puig, Mag. rer.nat., MSc 
Research Background: Psychology, Clinical research 
b Sabine Geiger-Gritsch, MMag. pharm., Dr. scient. med.  
Research Background: Pharmacy, Public Health 
b Tim Johansson, Mag. phil., MSc (since 01/10/2008) 
Research Background: Public Health 
b Stefan Mathis, Dr. med., Dipl.-Ing. 
Research Background: Medicine, Biomedical Informatics 
b Roman Winkler, Dr. phil, MSc (since 15/05/2008) 
Research Background: Communication Science 
 
team members 
a total of 16 persons 
= 14 FTE  
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Layout & Graphic Design: 
b Darko Blagojevic 
Trainees:  
b Elisabeth Breyer, MMag. 
Research Background: Health Sciences 
b Ines Schuhmacher, BA (21/08/ - 19/09/2008) 
Research Background: Public Health 
b Katharina Hintringer (01/10/2008 - 31/01/2009) 
Research Background: Social- and Health Management 
Junior Researchers: 
b Tessa Langley, BSc (15/10/2007 - 22/02/2008) 
Research Background: Economics 
b Elisabeth Breyer, MMag. 
Research Background: Health Sciences 
Literature Acquisition: 
b Johannes Setz 
b Laura Brückner 
b Mimoza Dulaj 
Student Assistants: 
b Johannes Flandorfer  
b Eva Salaberger 
Furthermore, there are also external experts working on several projects for 
the LBI-HTA. In 2008 those were: 
b Christopher Adlbrecht, Dr. med. 
Research Background: Medicine 
b Brigitte Freiesleben de Blasio, Dr. 
Research Background: Modelling 
b Manuela Göbl, Mag. 
Research Background: Health- and Nutrition Sciences 
b Anna Kis, Dr.med. 
Research Background: Medicine 
b Thomas Langer, Dipl.-Soz. 
Research Background: Social Science 
b Enzo Lauber, Dr. 
Research Background: Health Economics 
b Bernhard Martin, Dr. Mag. rer.soc.oec. 
Research Background: Sociology, Science Journalism 
b Ingrid Michl, Mag.  
Research Background: Pharmacy 
b Anna Nachtnebel, Dr. med., MSc PH (since 01/01/2009 employed as 
researcher at the LBI-HTA) 
Research Background: Medicine, Public Health 
many assistants 
external experts 
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b Christoph Pammer, DSA, MPH 
Research Background: Health management, Public Health 
b Claudia Pramesberger, Dr. med. 
Research Background: Medicine 
b Sonja Reiselhuber, Mag.  
Research Background: Nutrition Sciences 
b Irmgard Schiller-Frühwirth, Dr. med. 
Research Background: Medicine, Public Health 
Personnel, who left the LBI-HTA in 2008: 
Dr. Gerald Gartlehner, MPH was a member of the LBI-HTA research staff 
who worked in the domain of medicine and public health. After leaving the 
institute in the end of February 2008, he became director of the newly estab-
lished “Department for Evidence-based Medicine and Clinical Epidemiol-
ogy” at the Danube University Krems.  
Mag. Beate Guba, MSc was the information specialist at the LBI-HTA until 
June 30 2008, where she was mainly responsible for literature search and - 
acquisition. Above all, her field of activity ranged from general knowledge 
management to various duties connected with the library, the document 
server and also the website (webmaster). Beate Guba is now living and work-
ing in Berlin.  
The Ludwig Boltzmann Institute for Health Technology Assessment, resp. 
its staff, is a member of the following international and national organisa-
tions: 
b HTAi (Health Technology Assessment international) 
b INAHTA (International Network of Health Technology Assess-
ment) 
b EUPHA (European Public Health Association) 
b DNEbM (German Network for Evidence-based Medicine) 
b German Society for promoting HTA 
b ÖGPH (Austrian Society for Public Health) 
b EuroScan (International Information Network on New and Emerg-
ing Health Technologies) 
b EUnetHTA (European network for Health Technology Assessment) 
In 2005 Claudia Wild was appointed to the Supreme Health Council (advi-
sory committee of the Health Minister) for the first time. She has now been 
called up for its second period (meetings on April 12 and November 15 
2008). Additionally, Claudia Wild is a member of the Viennese Council of 
Bioethics and of the Scientific Advisory Committee of the EBM-Working 
Group at the Austrian Federation of Social Insurances (meeting on October 
24 2008). She terminated her appointment as a member of the Board of the 
Austrian Society for Public Health (ÖGPH) at the end of 2008. Brigitte Piso 
was consequently called up to carry out this role. Since autumn 2008 Clau-
dia Wild has also been a member of the Scientific Advisory Group of 
DAHTA@DIMDI as well as of the International Advisory Board of the 
“German Journal for Evidence and Quality in Healthcare” (ZEFQ). 
Ingrid Zechmeister is a member of International Health Economics Associa-
tion (IHEA) and of the “Development Board of the University of Applied 
institutional 
memberships  
individual  
memberships  
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Sciences for Biomedical Analytics” (Fachhochschulentwicklungsrat für 
biomedizinische Analytik). 
Since November 2008 Brigitte Piso has been a co-opted board member of the 
Austrian Society for Public Health (ÖGPH). 
Erwin Falkner is a member of the Tissue Engineering International & Re-
generative Medicine Society (TERMIS) and the The Biomaterial Network 
(BiomatNet). 
Philipp Mad is a member of the European Pathway Association (EPA). 
Sabine Geiger-Gritsch is a member of the German Society of Medical In-
formatics, Biometrics and Epidemiology (GMDS) and of the International 
Society for Pharmacoeconomics and Outcomes Research (ISPOR). 
1.5 Infrastructure 
The office of the LBI-HTA (279 m² in total) possesses seven separate rooms 
and a 70 m² library/seminar room. At the end of 2008, the institute was 
equipped with 16 personal computer workstations. For 2009 no further addi-
tions are planned. 
By the end of 2008 the LBI-HTA’s library has expanded its stock to 360 
monographs and many important bibliographic online database licences. In 
addition to the already existing databases Medline (Ovid) and Scopus (El-
sevier), Embase (Elsevier) and UpToDate were licensed in 2008. 
1.6 Highlights of the Year 2008 
In 2008 six new team members joined the LBI-HTA (four researchers, one 
scientific assistant/scientific communications and one information special-
ist). The staff expansion needed to be well planned in terms of organisation, 
content and infrastructure. A further office room was rented from October 
2008. In order to facilitate familiarisation with work tasks and of rapid inte-
gration, every new team member was assigned a senior researcher as a su-
pervisor and mentor. In addition, the weekly team meeting (Tue, 2pm) con-
tinued to be important and indispensable to communication and the work-
ing atmosphere within the LBI-HTA. 
The seminar series “decision support in health care” was also very popular 
and well-attended in 2008. On average between 20 and 50 persons visited 
these monthly lectures, as did many LBI-HTA researchers. As a result of re-
ceiving such a large number of applications, an alternative room at the 
neighbouring “Society of Physicians in Vienna” had to be rented for two of 
the seminar dates.  
Our electronic HTA newsletter, which is published 10 times p.a. and dis-
tributed to about 900 people in Austria and Germany, has received positive 
feedback. In 2008 the download website of the HTA newsletter 
(http://hta.lbg.ac.at/de/newsletter.php?iMenuID=63) counted between 406 
(December 08) and 2.273 (November 08) visits, with a total annual number 
of 12.478 visits. 
office space and 
equipment  
library 
focus: staff expansion 
seminar series „decision 
support in health care “ 
HTA newsletter-
download: between 
400 and 2.200 visits, a 
total number of: 12.478 
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According to the access statistics of the LBI-HTA’s website and its numer-
ous pages (http://hta.lbg.ac.at), about 1.4 million hits (1.399.565) were regis-
tered in the year 2008. In 2008, the number of hits was highest in November 
(161.192), and lowest in January (86.2966). 
Figure 1.6.1: Website – Hits and visits 2008  
In 2008 mainly print media, but also radio- and tv-stations published a total 
of 50 articles/reports/press notices reporting on the LBI-HTA or its team 
members. The LBI-HTA press review 2008 is available online at (German 
version only): http://hta.lbg.ac.at/de/content.php?iMenuID=82 
After an overview of several international Horizon Scanning Systems, the 
development and piloting of a Horizon Scanning Programme in Oncology 
has been followed. The programme was presented to the public at the HTAi-
conference (5th Annual Meeting) in Montreal/Canada (06/-10/07/2008). 
Since then the LBI-HTA has been one of 19 institutions to carry out inde-
pendent horizon scanning. In November 2008 the LBI-HTA also became a 
member of the international “EuroScan” cooperation.  
Co-funding from the European Commission for the EUnetHTA Project 
ceased in 2008. Therefore, on June 16 2008 the EUnetHTA Steering Com-
mittee endorsed a proposal for a permanent collaboration, called the 
‘EUnetHTA Collaboration’. To ensure the continuation of EUnetHTA in the 
interim period of 2009, a group of 25 partner organisations, so-called “found-
ing partners”, from 13 EU Member States +Norway and Switzerland, met at 
the LBI-HTA in Vienna on September 20 2008 in order to develop a strate-
gic concept of sustainable coordination of the network, and the careful in-
volvement of partners in the EU Joint Action on HTA together with others. 
Each year, the Austrian ministry of health receives numerous suggestions for 
individual medical services (MELs) to be included into the MEL catalogue, 
thereby making them reimbursable. An evaluation of such new medical ser-
vices, related to efficacy and safety, was conducted for the first time in 
2007/08. In order to be able to provide these rapid assessments in just a view 
weeks (from mid-January to the end of March) both a methodological and an 
organisational challenge had to be overcome. However, the LBI-HTA team 
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close international 
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was successful and a number of publications have already resulted from 
these reports. In 2009 cooperation with the NUB–method (New diagnosis 
and treatment procedures), which is the German equivalent to the Austrian 
MEL, will be tested. Both methods lead to similar, largely identical results 
as regards medical techniques. 
In order to continue exchange and strengthen cooperation with the Institute 
of Public Health, Medical Decision Making and HTA at the Private Univer-
sity for Health Sciences, Medical Informatics and Technology (UMIT) and 
the Department for Evidence-based Medicine and Clinical Epidemiology at 
the Danube-University Krems (DUK), a two-day network meeting (includ-
ing a hiking tour) was been organisation in Ebensee/ Upper Austria (29/-
30/09/2008).  
On May 18 2008 a small round of friends and partners came together at the 
Villa Aurora/Vienna to celebrate the two-year anniversary of the LBI-HTA. 
In the course of this successful evening employees presented a newly created 
poster-template to the director (including the humoristic results of a study 
carried out the team: “How HTA changed our lives – a before and after 
study”). 
During the LBG-ceremony at the Semper Depot on April 22 2008, already 
existing and recently founded Ludwig Boltzmann Institutes were officially 
presented to the public and celebrated.  
Nine team members of the LBI-HTA attended the HTAi-conference (5th 
Annual Meeting) in Montreal/Canada (06/-10/07/2008). In addition to pro-
fessional participation, participants used the opportunity for private interna-
tional networking. 
 
close national 
cooperation with  
UMIT & DUK 
LBI-HTA 
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1.7 Research Programme 
The work program of the LBI-HTA consists of five programme lines, which 
will be briefly described. All projects will be explained in chapter 2 (re-
search), within the context of the different programme lines. 
Comprehensive assessments of health interventions & evidence-based 
health services research 
HTA can now look back on 20 years of methodological developments and in-
ternational harmonisation. „Traditional” assessments answer questions on 
new/innovative or established medical interventions such as  
b Is the intervention effective, does it work? 
b For whom, which subgroup of patients? 
b At what cost? 
b How does the intervention compare with alternatives? 
Unlike traditional HTA, evidence-based health services are still young, but 
are based on the same basic research principles: systematic literature search 
and analysis, transparent presentation of sources, process and results and in-
terdisciplinary perspectives. In contrast to the results from the critical ap-
praisal of medical interventions, the results from health services research are 
deeply anchored in the health systems concerned and cannot be as easily 
transferred into other systems. The research field of evidence-based plan-
ning follows the approach of distinguishing between demand and need and 
of critically questioning the actual utilisation of health services.  
For that reason, the LBI-HTA, as an HTA institute in a small country, is de-
voted to bringing international HTA into the national context and to further 
developing methods of evidence-based health services research. 
Scientific support of health policy and decision-maker networks 
Policy-relevant decisions are traditionally reached on the basis of a consen-
sus of high-ranking experts in boards and committees. This process of exclu-
sively expert-based (so-called eminence-based) decision-making is highly 
prone to bias, conflict of interests and doctrine. It is the aim of evidence-
based support to decision-making to collect and present recent research re-
sults and to provide a more rational and transparent input to the process of 
health policy decision-making, independent of influences from interest 
groups. The aim is to shape the process in the long term by systematically 
questioning marketed information and by asking for sound evidence. 
It is the task of the scientific support of health policy and decision-maker 
networks to react rapidly to demand and to present the evidence to decision-
makers in a transparent and readable format. 
Health Technology Assessment in hospitals 
The informal „HTA in hospitals” network consists of a group of about 20 
high-ranking decision-makers (medical directors and quality managers) 
from nearly every Austrian hospital cooperation. The network meets twice a 
year (June and October) in order to obtain informative HTA input into 4 key 
topics, to discuss them and to exchange ideas on regulation and reimburse-
ment issues. 
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The task of the LBI-HTA is to coordinate the meetings, to request and col-
lect current topics and to prepare the presentations. The format of the meet-
ings is for each topic to be presented from the HTA perspective and by an 
invited clinical expert, which subsequently leads into a structured discus-
sion.  
Scientific decision support of the Health Ministry 
It is the task of the LBI-HTA to provide - on request - scientific support to 
different committees of the Austrian Health Ministry (BMG, 
http://www.bmg.gv.at/): 
b to support the Medical Advisory Group in the maintenance of the 
Austrian medical procedure classification (Austrian DRG Cata-
logue) with evidence analysis of new/innovative or established 
medical interventions. 
b to react to information enquiries in the Supreme Health Council 
(advisory committee of the Health Minister). 
Public understanding and research transfer 
Quite often - steered by early media coverage - the demand for 
new/innovative health care interventions emerges, even before market ap-
proval or reimbursement. „Public understanding” is both the transfer of 
knowledge about market forces and about methods for critically questioning 
the evidence presented on effectiveness and cost-effectiveness, appropriate-
ness, and methodological support for the differentiation between new and 
innovative interventions. „Public understanding” is meant to contribute to a 
better understanding of true effectiveness and, at the same time, to a democ-
ratic shaping of benefit packages. 
The intention of „public understanding and research transfer” is to build up 
- through presentations, seminars, monthly newsletter, a user-friendly web-
site and search support - a critical mass of patients, journalists, representa-
tives of the health administration, academia etc. that questions the informa-
tion presented and asks for sound evidence before decision making. 
HTA-implementation: Development and informing on effective policy in-
struments 
Evidence for the effectiveness and cost-effectiveness of numerous technolo-
gies and interventions can often only be presented after market approval and 
several years’ use under real clinical conditions. However, even then, ineffec-
tive technologies are widely spread and applied. Since it is ethically not jus-
tifiable to withhold true medical innovations from patients, and because 
pseudo-innovations absorb a lot of resources, taking new technologies under 
„surveillance” or „limited application” at specific medical centres is increas-
ingly frequently considered. Consequently, final decisions on reimburse-
ment are made only after patient-relevant outcome data become available. 
Methods for limited application and the assessment and appraisal of tech-
nologies and interventions after having obtained patient-relevant outcome 
data are still young. In this programme line, they will be further developed 
and applied. 
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International cooperation / HTA Best Practice  
The EUnetHTA project started in January 2006 and for 3 years was financed 
by DG SANCO/Health & Consumers in the context of the „Community Ac-
tion in the Field of Public Health programme”. The overall aim of 
EUnetHTA is to establish an effective and sustainable European network for 
HTA that informs policy decisions. Since all western countries and increas-
ingly some new EU member states use HTA as a policy-tool, cooperation and 
collaboration is of utmost importance in order to reduce redundancies. 64 
institutions from 29 European countries cooperate within EUnetHTA. The 
reduction of overlaps and duplication, the transferability of HTA-reports 
within Europe and the strengthening of links with healthcare policy are the 
objectives of EUnetHTA. 
By the end of 2008 the LBI -HTA was a co-initiator and leading partner in 
EUnetHTA and managed work package 7 in close cooperation with the 
French HAS/Haute Authorité de Santé. 
Co-funding from the European Commission for the EUnetHTA Project 
ceased in 2008. The experience of collaboration among partners in 
EUnetHTA is positive and to ensure that communication, collaboration 
networks and activities are continued, the partners have decided to create a 
sustainable, permanent European HTA collaboration. This will involve HTA 
Agencies and other producers of HTA information, with support from Euro-
pean governments, the European Commission and international health or-
ganisations.  
Therefore, on June 16 2008 the EUnetHTA Steering Committee endorsed a 
proposal for a permanent collaboration, called the ‘EUnetHTA Collabora-
tion’. The mission of this collaboration is to support effective HTA collabo-
ration in Europe that brings added value at the European, national and re-
gional level. 
To ensure the continuation of EUnetHTA in the interim period of 2009, a 
group of 25 partner organisations, so-called “founding partners”, from 13 
EU Member States (+Norway and Switzerland) have developed a strategic 
concept with regards to a sustainable coordination of the network and the 
careful involvement of Partners in the EU Joint Action on HTA together 
with others. 
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2 Research 
2.1 Projects and scientific advisory service 
Clavicular fractures – A systematic review of efficacy and safety of dif-
ferent treatment options 
Project leader: Rosemarie Felder-Puig 
Duration:  08/2008 – 12/2008 
Background: Clavicular fractures are common injuries and represent 10-15% 
of fractures in adults and 20-25% of fractures in children. Midshaft fractures 
account for approximately 80% of all clavicular fractures. Conservative 
treatment with a sling or figure-of-eight bandage is generally acknowledged. 
Alternatively, there are operative treatment procedures available. However, 
the optimal treatment option for the various fracture types remains contro-
versial.
Aims and research objectives: The objective of the HTA-report is to summa-
rise and compare study results to provide more conclusive evidence for op-
timal therapy planning. What evidence exists on the efficacy and safety of 
different treatment options for the management of clavicular fractures given 
fracture type and other parameters? Is it possible to compile a clinically 
practicable algorithm on the basis of the available evidence? 
Method: Systematic literature search in various electronic databases - pe-
riod: 1998-2008; hand search via Scopus. 
Publication: HTA Project Report 17 - http://eprints.hta.lbg.ac.at/816/ 
Reimbursement process – An analysis of international practice models 
for maintaining the health benefit baskets of solidly financed health 
care systems 
Project leader: Elisabeth Breyer 
Duration:  06/2008 – 12/2008 
Background: In view of increasing health care costs and budgetary problems, 
a systematic reimbursement decision process for medical technologies be-
comes an important instrument of allocation. Coverage decisions have a 
monetary impact on patients and service providers, and at the same time 
they implicitly decide whether a technology is implemented and more evi-
dence can be gained. In Austria an overall catalogue of outpatient medical 
care has been developed on and will require a consistent process for mainte-
nance and further development. Within this context, international practice 
models of reimbursement processes and their features are analysed so that 
critical success factors can be derived. 
Method: Hand search on websites and in databases, application processes for 
reimbursement of medical interventions and associated literature have been 
identified, systematic literature search and expert opinions. 
The following processes have been analyzed: Australia (MSAC), Denmark 
(mini-HTA), Spain (GANT), Germany (G-BA, KBV innovation service), 
England (NICE single technology appraisal), France (HAS application form 
for medical procedures), Switzerland (BAG) and Austria (MEL, OÖGKK). 
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From the eight identified and specified country models, Germany, France 
and Switzerland, which are to some degree comparable to the Austrian 
health care system. Additionally, the Austrian pharmaceutical funding proc-
ess, have been analysed according to the process phases and aspects. 
Publication: HTA Project Report 22 - http://eprints.hta.lbg.ac.at/817/ 
Statins: A comparison between predicted and actual effects on popula-
tion health in Austria (Parts II + III) 
Project leader: Ingrid Zechmeister 
Duration:  2007 – 2008 
Background und Research objective: Since the 1990s, statins (cholesterol 
lowering drugs) have been increasingly used to prevent cardiovascular dis-
eases. In clinical studies they have been shown to be effective. Compared to 
placebos, a relative risk reduction with respect to mortality and morbidity 
has been demonstrated. Apart from the clinical benefit, it has been expected 
that the use of statins will reduce the number of cardio-vascular interven-
tions (such as coronary artery bypass grafting) and thus will result in de-
creasing hospitalisation. This should eventually guarantee favourable cost-
effectiveness results. The question to be answered by the project is whether 
there is empirical evidence to support this hypothesis, not only on the basis 
of clinical studies but under real conditions of use in Austria.  
Method: In part 1 of the project a systematic review of economic evaluations 
which addressed statin therapy for the secondary prevention of cardio-
vascular diseases was carried out. In part 2 a decision analysis model, which 
was initially developed for the UK, has been adapted with Austrian utilisa-
tion and cost data in order to be able to determine a realistic prognosis for 
cost-effectiveness of statins in Austria. For this purpose, a workshop was 
been conducted, where the UK model was adapted in cooperation with the 
University of Sheffield and the Federation of Austrian Social Security Insti-
tutions. Based on these results, part 3 of the project empirically analyses the 
impact of statin therapy on actual hospital interventions in Austria. 
Publications:  
[Part I: ITA Project Report 30 - http://eprints.hta.lbg.ac.at/588/] 
Part II: HTA Project Report 18 - http://eprints.hta.lbg.ac.at/803/ 
Part III: HTA Project Report 19 - http://eprints.hta.lbg.ac.at/804/ 
Clinical applications of tissue engineering: An outline of the field of re-
search, Austrian aspects, and critical analysis of selected approaches 
Project leader: Erwin Falkner 
Duration:  05/2007 – 08/2008 
Background: Tissue Engineering (TE) is defined as the use of autologous or 
allogenous cells, mostly in a matrix of proliferation and/or differentiation 
enhancing environment to stimulate tissue and organ regeneration in pa-
tients of varying clinical conditions. State of the art of TE projects vary from 
prevalent clinical usage of in vitro cultivated autologous chondrocytes for 
knee defects to future visions of whole organ systems. So far, benefits and 
risks for patients, advantages to common therapies as well as costs have only 
been evaluated for certain aspects of the field.  
Aims and research objectives: The goal of the project is a review of the cur-
rent international state of TE, with a focus on the analysis of structural ques-
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tions on Tissue Banks in the Austrian theatre. A further aim is to critically 
evaluate selected fields of application in terms of patient value. 
Method: Systematic investigation of TE applications and analysis of current 
evidence of its use; classification into six categories: conceptualised, experi-
mental, animal testing, pre-clinical phases, rife clinical application, abjected 
onsets; assessment of selected TE approaches with clinical relevance in Aus-
tria; analysis of Austrian guidelines for tissue banks, structural conditions, 
assurance of quality. 
Publication: HTA Project Report 13 - http://eprints.hta.lbg.ac.at/807/ 
Economic aspects of clinically effective and efficient models of health 
services in alcohol addiction treatment 
Project leader: Philipp Radlberger  
Duration:  10/2007 – 10/2009 
Part I: International models and approaches of outcome measurement 
(completed) 
Part II: Selected models of integrated care and their evaluation (completed) 
Part III: Economic analysis of clinically and operationally effective models 
and transfer to the context of the region of Salzburg (Salzburger Landesk-
liniken) 
Background: Increasingly, psychiatric and socio-medical therapeutic institu-
tions have to deal with the discussion and measurement of their outcomes. 
Given this fact, the project, which is structured in three parts, aims to pro-
duce a synthesis of published knowledge and its analysis in order to gain 
new knowledge for concrete evaluations of therapeutic institutions. Several 
highly heterogeneous approaches exist in the organisation of the services: 
easily accessible outpatient therapies, day-care, as well as inpatient services. 
There is relatively little comparative evidence of clinical effectiveness of the 
different approaches, treatment results and costs.  
Aims and research objectives: To give an overview of the different treatment 
models, to analyse some models of integrated care, to reach conclusions 
about the evaluation of cost-effectiveness analysis of in- and outpatient 
therapies for people suffering from alcohol addiction, to transfer the main 
features of a model of integrated care services to the region of Salzburg and 
to carry out an economic evaluation of the existing and a potential inte-
grated care model. 
Method: Part I: Systematic review, literature- and data analysis; Part II: Ad-
ditional search of published and grey literature; hand search and internet re-
search for chosen models of good practice; direct contact and expert inter-
views; systematic organisation analysis of the three examples of integrated 
care according to their procedural design, gateway communication struc-
tures; analysis of grey literature and cost data available; formulation of qual-
ity indicators which could be benchmarks for other models of service of in-
tegrated care in alcohol addiction treatment; 
Publication (Part I & Part II): HTA Project Report 10 - 
http://eprints.hta.lbg.ac.at/813/ 
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Clinical pathways: Systematic review of outcome parameters and  
effectiveness  
Project leader: Philipp Mad 
Duration:  07/2007 – 09/2008 
Background: In recent years clinical pathways have been increasingly intro-
duced in western countries as instruments for quality assurance. A survey 
among users of clinical pathways in 23 countries found that clinical path-
ways are mainly perceived as tools for improving multidisciplinary ap-
proaches to enhance quality and evidence based care. These days, clinical 
pathways are primarily applied in acute health care settings. Despite world-
wide increased implementation of clinical pathways many questions remain 
as to their actual impact: on the one hand there are uncertainties about their 
exact definition, scope and profile in contrast to other instruments of quality 
assurance. On the other hand, their intention, value and measurable benefit 
are not entirely clear.  
Aims and research objectives: The objective of this assessment is to look 
closely at the potential to for evaluating the impact of clinical pathways in 
general and to identify outcome indicators on the basis of previous evalua-
tions, and to give an overview of the effectiveness of clinical pathways as 
measured by these outcome indicators. 
Method: The appraisal orientates itself according to the methodology devel-
oped by the propositions of the Cochrane Effective Practice and Organisa-
tion of Care (EPOC) Group for measuring the impact of organisational, 
regulative, educative and financial interventions in health. 
Publication: HTA Project Report 16 - http://eprints.hta.lbg.ac.at/801/ 
Outpatient cardiac rehabilitation: Outcome measurement and evalua-
tion  
Project leader: Brigitte Piso 
Duration:  07/2007 – 09/2008 
Background: Cardiac rehabilitation is an important therapeutic intervention 
to facilitate the reintegration of patients into society, family and work fol-
lowing acute cardiac events. Phase I of the cardiac rehabilitation consists of 
the early mobilization during the hospital stay after an acute cardiac event. 
Phase II consists of various other interventions, lasting 4 to 6 weeks, and 
administered in an outpatient or inpatient setting.  
Aims and research objectives: The objective of this systematic review is to 
assess the comparative efficacy and safety of inpatient and outpatient car-
diac rehabilitation in defined populations. Furthermore, the report will ex-
amine how health systems, compared to the Austrian one, have evaluated the 
quality of cardiac outpatient rehabilitation. Based on these findings, the re-
port will discuss valid outcome parameters that could be used to evaluate 
cardiac outpatient facilities in Austria. 
Method: Systematic review and analysis on outcome measurement and 
evaluation of outpatient cardiac rehabilitation. 
Publication: HTA Project Report 15 - http://eprints.hta.lbg.ac.at/800/ 
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Nonspecific acute and chronic back pain: Evidence based diagnosis and 
treatment in practice – options and limitations 
Project leader: Rosemarie Felder-Puig 
Duration:  06/2007 – 07/2008 
Background: Nonspecific acute and chronic back pain, primarily in the 
lower back, are amongst the most frequent pain problems, although esti-
mates of their prevalence and economic consequences vary greatly between 
studies. Since 2000 there has been increasing support in the literature for fa-
vouring proactive and educational therapies over passive and surgical proce-
dures. Although a number of systematic reviews, HTAs and guidelines are 
available for diagnosis and treatment of back pain, it seems that the evidence 
often does not inform everyday clinical decisions of physicians and/or the 
acceptance and compliance of patients. Nevertheless, there is widespread 
agreement that adherence to evidence-based practice will help improve back 
pain patient outcomes and reduce costs.  
Aims and research objectives: The aim of this HTA is to provide a systematic 
review of current best evidence of effective prevention strategies and diag-
nostic and therapeutic modalities. We will address discrepancies in recom-
mendations across guidelines, their methodological quality and the fact that 
most of them are monodisciplinary rather than multidisciplinary. Further-
more, we will broach the issue of scarce availability of high quality informa-
tion for patients.  
Method: Evaluation of current German-language guidelines and comparison 
to results of recent meta-analyses, systematic reviews and HTAs; collection 
of Austrian epidemiological data; experts' opinions about practice and dis-
crepancies. 
Publication: HTA Project Report 12 - http://eprints.hta.lbg.ac.at/794/ 
Autologous chondrocyte implantation (ACI) for cartilage defects of the 
knee 
Project leader: Erwin Falkner 
Duration:  08/2008 – 01/2009 
Background: The problem of treatment of cartilage defects of the knee has 
still not been completely solved. High incidence rates of such defects of ar-
ticular cartilage of the knee currently lead to various innovative therapy op-
tions. The classic version of autologous chondrocyte implantation (trans-
plantation) implements the targeted implantation of a chondrocyte cell sus-
pension (cultivated in vitro from biopsies of the patients). There exist a 
number of ACI protocols, some also using biomaterials. Defects of articular 
cartilage of the knee have varying origins, caused by injuries as well as de-
generative diseases like arthritis. Therapy of focal articular cartilage defects 
remains a complex problem for orthopaedic surgeons and patients. Injuries 
show a low healing capacity and can develop into osteoarthritis. Pain man-
agement is the first indication for surgical treatment, second comes the delay 
of cartilage degeneration. Therapy options include micro fracture (cartilage 
regeneration induced by tiny bone fractures next to the original injury), mo-
saicplasty, osteochondral autologous or allogenic transplantation of bone 
and cartilage and, of course, the ACI. 
Aims and research objectives: Systematic review including literature analysis 
on effectiveness and safety of ACI methods for patients with cartilage defects 
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of the knee joint. Are the varying ACI methods compared to standard thera-
pies (no intervention, micro fracture, autologous/allogenic cartilage trans-
plantation, mosaicplasty) a sustainable effective and safe alternative for pa-
tients with cartilage defects of the knee joint? 
Method: Systematic research in the databases: Medline, Embase, HTA 
Datenbank/ NHS EED des CRD York, INAHTA, CADTH, NCCHTA, 
NICE; hand search via Scopus; period 1985 – 2008; 
Folic acid supplementation 
Project leader: Irmgard Schiller-Frühwirth, Claudia Wild 
Duration:  09/2008 – 12/2008 
Background: Folic acid, as a water-soluble B-vitamin, is very important for 
women of childbearing age because of its key-role in many metabolic proc-
esses, particularly in cell growth and cell regeneration. A folic acid defi-
ciency in the early stages of pregnancy could lead to defects of the spinal 
column, so-called neural tube defects. In contrast to adolescents and adults, 
who normally need about 400 microgram folate equivalents a day, pregnant 
and breastfeeding women are in need of 600 microgram. German-speaking 
countries document about 1 neural tube defect per 1000 births. In the case of 
recurrence, the risk is about 3% and after a second occurrence about 10%. 
On average, between 300.000 and 400.000 children are affected by these de-
fects world-wide. In Austria the frequency ranges from 70 to 80 cases per 
year. Recent studies have shown that the prevalence of neural tube defects 
can be reduced by the administration of folic acid before conception. The 
natural source of folic acid is food (folate). Artificially produced folic acid is 
contained in dietary supplements and in enriched foods. Hence the possi-
bilities of an obligatory folic acid fortification of staple foods (such as flour), 
the selective intake of foods which are rich in folic acid, as well as folic acid 
tablets have been discussed world-wide, and are currently being discussed in 
Austria.  
Aims and research objectives: This review was requested by the Austrian 
Ministry of Health in order to provide a scientific basis for a decision for or 
against an obligatory folic acid enrichment of flour in Austria. The aim of 
the project is to describe the recent evidence on benefits and risks, as well as 
efficacy and safety of potential flour enrichment with folic acid. Efficacy was 
analysed with regard to the decrease of neural tube defects and other birth 
deformities, the risk of aborts and twin births, the prevalence of cardiovascu-
lar diseases, breast cancer, colorectal carcinoma, and also the safety regard-
ing masking of a vitamin B 12-deficiency and anti-epileptic drug therapy. 
Further questions were: Which potential long-term effects of folic acid over-
supply are predicted? Which ethical and social aspects have to be taken into 
consideration in case of a nationwide intervention such as the obligatory for-
tification of foods? 
Method: Systematic research in relevant databases such as Ovid Medline, 
Embase, DARE ,NHS, EED, HTA, Cochrane, World of knowledge (Wok); 
period 1993 – 2008; systematic review. 
Publication: Responsibility of the Austrian Health Ministry (BMGFJ) 
 
programme line  1 
Research 
LBI-HTA | 2009 27 
Evidence based health service planning and evaluation  
Project leader: Stefan Mathis 
Duration:  10/2008 – 05/2009 
Background: The delivery of health services should meet the population’s 
needs and include an efficient use of health care resources. Recent nation-
wide surveys in Germany (Sachverständigenrat für Konzertierte Aktion im 
Gesundheitswesen), the USA (Institute of Medicine (IOM) of the National 
Academies) and Great Britain (Wessex Institute of Public Health Medicine) 
show substantial deficits in the information about the status of needs and 
the status of the current supply (unmet needs, ineffective health care, ineffi-
cient health care and inappropriate health care). Additionally, it is stated 
that insufficient use of health service research is made in important fields, 
and also that advanced methods in health service research need to be estab-
lished.  
This project addresses health services planning as a key factor for structur-
ing the health system. Information about the status quo of care delivery as 
well as the status quo of the population’s morbidity enters the process of 
planning. This information is considered for health governance plans. Scien-
tific reflection is needed to utilise established technical knowledge about 
certain aspects and future approaches of health services planning. This in-
cludes evidence about the planning method itself as well as elements of evi-
dence for planning. Elements include information gathering strategies, 
methods to measure the confirmed need, methods to calculate prospective 
developments and methods to assess the efficacy and efficiency of health 
technologies. The further development and consolidation of methods of evi-
dence based health service planning may impact short and long term actions 
of health policy decision making, organisation, steering and financing the 
health system. 
Aims and research objectives: The aim of the project is to identify health ser-
vice research methods – especially methods of health service planning, to 
analyse them and to customise these methods for the utilisation for the in-
ternal health technology assessment agenda. 
Methods: Systematic literature review and analysis of the results (search in 
medical portals and hand search, including health service research institu-
tions). 
Classification of severity for neuro- and trauma rehab patients  
Project leader: Christoph Pammer (Part I), NN (Part II) 
Duration:  09/2008 – 12/2009 
Background: While progress and innovations in modern medicine and am-
bulance systems have led to increased survival after acute disease and severe 
trauma, rehabilitative interventions have not developed accurately. Due to 
complexity, neurological rehabilitation is a field of specialized knowledge 
and interdisciplinary intervention, and demands a high level of integration 
from health professionals and their workforce organisation. In order to be 
able to evaluate rehabilitative interventions - or even optimise them –a series 
of instruments has been created in the field of research, which all orient 
themselves according to the International Classification of Functioning, Dis-
ability and Health (ICF) of the WHO. 
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Aims and research objectives: The aim of the assessment is to systematically 
analyse methods of severity classification and outcome measurement in neu-
rological rehabilitation, not only considering its clinical relevance (test qual-
ity and prognosis), but also evaluating performance of care delivery depend-
ing on input, incentives and other measures that determine effectiveness. 
The goal of the report is to provide the knowledge needed for evidence based 
decision-making in supervising the system of neurological rehabilitation. 
Method: Systematic literature review and analysis of the results in the online 
portal: Medline, Embase, Cochrane and HTA database; period: 1990-2008. 
Child and adolescent psychiatry – Evaluation of therapy outcomes  
Project leader: Roman Winkler 
Duration:  10/2008 – 05/2009 (Part I) 
Background: The treatment of mentally disordered children and adolescents 
largely uses extensive therapy concepts including medical, psychotherapeu-
tic and socio-pedagogical interventions, which are adjusted to patients’ indi-
vidual needs. However, in the context of therapeutic evaluations and quality 
assurance, there is a lack of evidence regarding therapeutic outcomes (such 
as clinical improvements, quality of life) and satisfaction rates of patients 
and their relatives concerning therapy care. Additionally, there is a need for 
socio-economic long-term outcomes assessing parameters such as school suc-
cess or working ability of mentally disordered children and adolescents. Re-
search also needs to focus on economic evaluations, which relate therapy 
outcomes to resource management. This particularly holds true for German-
speaking countries, while such comprehensive evaluations have already been 
set up in several Anglo-American countries. Furthermore, the small number 
of available studies makes it difficult to draw clear conclusions from avail-
able therapy outcome indicators and mental health care options for children 
and adolescents. Hence, meaningful evaluations of therapy programmes are 
essential for the further development and financing of child and adolescent 
psychiatric health care as well as for the practical psychiatric therapy.  
Aims and research objectives: The project includes two main foci: In the first 
part of the report, it is envisaged to carry out a systematic review of existing 
methods to evaluate therapy programmes, to identify applied instruments 
and research tools, as well as to analyse therapy outcomes (published evalua-
tions) regarding outcome parameters (e.g. clinical pathology, quality of life, 
satisfaction of patients and their relatives with therapy programmes, socio-
economic long-term outcomes and cost-effectiveness), in order to identify 
possible benchmarks. In cooperation with the ‘Christian-Doppler-Clinic’ in 
Salzburg (and maybe with further Austrian hospitals), the second part of the 
proposed study will adopt and measure those outcome parameters that were 
extracted from the systematic review as being useful for an evaluation of 
psychiatric treatment of children and adolescents. Subsequently, this project 
attempts to contribute to the improvement of the empirical evidence, which 
is particularly insufficient in the field of child and adolescent psychiatric 
health care in Austria. Detailed aims and research objectives of part II will 
be developed after the completion of part I. 
Method: Systematic literature search of studies/reports in medical portals 
(Ovid Medline, Embase, CRD databases, PsycINFO, EconLit, ISI Web of 
Science), period 1985-2009; hand search; systematic literature review (part 
I).  
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Strategies for preventing preterm labor  
Project leader: Philipp Mad, Sabine Geiger-Gritsch 
Duration:  10/2008 – 05/2009 
Background: Preterm birth is associated with an increased risk of mortality 
and morbidity for the infant. Treatment strategies aim to delay labour to 
improve perinatal outcomes by allowing the foetus to mature further before 
birth, and to provide lung maturation by antenatal corticosteroid admini-
stration. Antenatal transfer of the mother to a tertiary care hospital may also 
be possible when preterm labour is delayed. Bed rest is widely recommended 
in a hospital or at home for the prevention of preterm birth as first step 
treatment, however, evidence on its effectiveness is lacking. The most com-
mon tocolytic agent to delay preterm birth in Austria is the Betamimetic 
Hexoprenaline (Gynipral®, Nycomed Austria). Over the last years a new to-
colytic agent, the Ocytocin Receptor Antagonist Atosiban (Tractocile ®, Fer-
ring, Sweden) was introduced to medical practice. Cochrane reviews found 
similar effectiveness of both tocolytic agents. However, an increasing use of 
Atosiban causing additional costs has recently been seen in Austrian hospi-
tals. 
Aims and research objectives: Synthesis of evidence based guidelines on to-
colysis and usage of Atosiban and Hexoprenaline; summary of evidence on 
effectiveness of Atosiban, Hexoprenaline and bed rest in women at risk of 
preterm labour; systematic review of cost-effectiveness of Atosiban and 
Hexoprenaline; 
Methods: Systematic review of evidence-based guidelines on tocolysis in pre-
venting preterm labour; update of Cochrane Reviews on Atosiban, Betami-
metics and bed rest using a similar search strategy; systematic review of cost-
effectiveness analyses including Atosiban and Hexoprenalin; 
Outpatient cardiac rehabilitation – Part II: Evaluation of outcome and 
effectiveness of outpatient cardiac rehabilitation 
Project leader: Michael Gyimesi 
Duration:  10/2008 – spring 2010 (Part 2) 
Background: Cardiac rehabilitation is an essential therapeutic step in ensur-
ing patient reintegration into work-, social- and family life following acute 
cardiac incidents or cardiac surgical procedures. Phase I of the cardiac reha-
bilitation is conducted in inpatients in terms of early mobilisation after an 
acute incident. The phase II cardiac rehabilitation normally takes 4-6 weeks 
and in many countries this is performed on an outpatient basis. In Austria 
only a small number of cardiac patients participate in outpatient rehabilita-
tion programs. However, the outpatient cardiac rehabilitation is assumed to 
be as effective and safe as inpatient rehabilitation care and in addition is 
more cost-effective. Phase III is always conducted on an outpatient basis and 
should support the sustainability of the rehabilitation. 
Aims and research objectives: On the one hand, the objective of the first part 
of this report (HTA project report 15 – http://eprints.hta.lbg.ac.at/800/) was 
to identify indicators which are suitable for the formative and summative 
evaluation of outpatient cardiac rehabilitation, and on the other hand to ana-
lyse appropriate methods or instruments to measure the processes and re-
sults. The aim of the second part is a long-term effect evaluation of the phase 
III outpatient cardiac rehabilitation. Which sustainable effects does the ad-
ditional phase III rehabilitation have following former in- and outpatient 
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cardiac rehabilitation (phase I+II), in contrast to no further outpatient af-
tercare? 
Method: Data evaluation for measuring long-term effects of already existing 
outpatient rehabilitation programs on the basis of the following data: sick 
leave, number of hospital visits, medication, early retirement, socioeconomic 
status. 
New technologies in acute stroke management -  
Telemedicine (telestroke) and interventional therapies  
Project leader: Tim Johansson  
Duration:  11/2008 – 07/2009 
Background: Acute stroke is the single biggest cause of major disability and 
is ranked as the second or third leading cause of death in most industrialised 
countries. Strokes often lead to disabilities of different type and severity, 
where in the majority of cases a cost-intensive long-term rehabilitation is 
needed. For more than a decade, two treatments for stroke patients have 
been shown to be effective: stroke-units (specialised centres) and systemic 
thrombolytic therapy for ischemic strokes. The problem is, however, that 
very few stroke patients have access to these therapeutic options. Reasons for 
this situation are the lack of experts and experience, especially in non-urban 
areas, as well as the very limited time available/left after onset for using a 
systemic thrombolytic therapy. Telemedicine methods can expand the 
knowledge and experiences from stroke units, and improve the delivery of 
systemic thrombolytic therapy for ischemic stroke patients. It is evident that 
the rehabilitation is most effective when it begins as soon as possible after 
stroke care. Different telemedicine methods have been described in the lit-
erature and also for the implementation in rehabilitation settings for stroke 
patients (e.g. home-based rehabilitation, Internet-based support to rural 
caregivers). Telemedicine methods may be important instruments in the or-
ganisation of rehabilitation services in order to improve the quality of stroke 
management. 
Aims and research objectives: The aim of the project is twofold. On the one 
hand to explore the effectiveness, quality and cost (cost-effectiveness) of 
telemedicine technologies in stroke management, and on the other hand to 
explore the effectiveness, quality and cost-effectiveness of interventional 
therapies in acute stroke management. 
Method: Systematic review and literature search of telemedicine technolo-
gies in stroke care management and interventional therapies in stroke. 
Individual medical services (MEL) 2008 
Project leader: Gerald Gartlehner, Rosemarie Felder-Puig 
Duration:  01/2008 – 04/2008 
Research objective: Each year, the Austrian Ministry for Health, Family and 
Youth receives suggestions for numerous new medical interventions to get 
reimbursed. The aim of this project is to develop a standardised tool to 
evaluate the scientific evidence for these interventions. The project consisted 
of two parts. The objective and result of the first part (July - December 2007) 
was the development of an algorithm to systematically evaluate the efficacy 
and safety of interventions suggested for inclusion in the MEL (individual 
medical services) catalogue for 2008. During the second part of the project 
(January - April 2008), 10 interventions that were prioritised by the Ministry 
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of Health for inclusion into the MEL catalogue were systematically evalu-
ated. The assessments were based on systematic reviews for each interven-
tion and the respective summaries of the scientific evidence according to the 
GRADE scheme. 
Method: Systematic reviews and summary of evidence according GRADE. 
Publications: Decision Support Documents (cf. HTA in hospitals, topics) – 
http://eprints.hta.lbg.ac.at/view/types/dsd.html 
On request of the OÖGKK and the OÖAK several rapid assessments/ deci-
sion support documents concerning alternative medicine therapies have 
been made:  
Project leader: Tessa Langley, Gerald Gartlehner 
Duration:  01/2008 – 2009 
Background: In contrast to complementary medicine therapies like home-
opathy, so-called “humbug”-methods are currently not allowed to be pro-
vided by a statutory health insurance-authorised physician, regardless of the 
private demands of the patient. In line with doctor’s fee negotiations in 1998, 
the safekeeping of the quality of medicine as an allowance in kind was re-
arranged.  
Aims and research objectives: Therapies which are proved to be ineffective 
or even dangerous for patients’ health are not allowed to be provided. For 
that reason, decision makers need evidence based data on approx. 20 “hum-
bug”-methods in order to be able to ex- or include therapies from the cata-
logue of benefits. Two of them have already been analysed and evaluated by 
the LBI-HTA (and two more will follow in 2009) in the form of decision 
support documents. 
2008: 
b Bach flowers 
b Aromatherapy 
2009:  
b Bioresonance therapy  
b Colon hydrotherapy 
Health Technology Assessment in hospitals 
Project leader: Claudia Wild 
Duration:  2 x p.a. 
HTA in hospitals, 03/06/2008, topics: 
b Enzyme replacement therapy (Olaf Bodamer/ MUW) 
b Individual medical services (MEL) 2008: 10 short presentations 
1. Lipid apheresis (Stefan Mathis/ LBI-HTA) 
2. Kypho- and vertebroplasty(Rosemarie Felder-Puig/ LBI-HTA) 
3. Incontinence therapy (Erwin Falkner/ LBI-HTA) 
4. Percutaneous aortic valve replacement (Claudia Wild/ LBI-HTA) 
5. Percutaneous pulmonary valve implantation (Philipp Mad/ LBI-
HTA) 
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6. Selective cell apheresis (Christopher Adlbrecht/ LBI-HTA) 
7. Rheopheresis® in patients with age-related macular degeneration 
(Claudia Wild/ LBI-HTA) 
8. Optical coherence tomography (Rosemarie Felder-Puig / LBI-
HTA) 
9. Stent-grafting of the ascending aorta (Brigitte Piso/ LBI-HTA) 
10. Cardiac contractility modulation (Christopher Adlbrecht/ LBI-
HTA) 
b Individual medical services (MEL): transparency in evidence, trans-
parency in processes? (general in-depth discussion) 
Method: Presentations 
HTA in hospitals, 14/10/2008, topics: 
b Cooperation 2009: NUB/ New diagnosis and treatment procedures (GE) 
& MEL/ individual medical services (AT): Co-ordination & process 
(Claudia Wild & Dr. Annette Busley – MDS/ The Medical Service of the 
Central Association of Health Insurance Funds). 
b Reimbursement process: An analysis of international practice models for 
maintaining the health benefit baskets of solidly financed health care 
systems (Elisabeth Breyer/ LBI-HTA) 
b Horizon scanning in oncology: Presentation of the new Austrian alert 
system, followed by a discussion about the adequate time, profile and 
target group for such early information products (Sabine Geiger-Gritsch/ 
LBI-HTA) 
Method: Presentations 
In line with programme line 3 - “public understanding and research trans-
fer” - the following activities take place on a regular basis: public seminar-
series („decision support in health care”), semi-public training on methodol-
ogy, HTA newsletter and website. 
Project leader: Claudia Wild, Gerda Hinterreiter 
Equity and resource allocation of medical interventions 
Project leader: Roman Winkler  
Duration:  05/2008 – 2009 (Conference date: March 2 2009; Urania Vienna) 
Background: The precarious situation of health care systems is evident. On 
the one hand, scarce budgets and high debts threaten the long-term financ-
ing of medical interventions for citizens. On the other hand, more and more 
cost-intensive medical innovations, which are to be made accessible to the 
public, appear on the market.  
Aims and research objectives: Apart from questions of use and efficiency of 
individual medical interventions, the FairHealth conference will deal with 
all those current problems and questions focusing on a fair distribution of 
medical performances. The need for such broad, public discussions primar-
ily results from the socio-political, individual and economic meaning of 
‘health’ as well as from recent debates concerning health care reforms. 
Method: In the light of this, the LBI-HTA has organised the FairHealth con-
ference on March 2 2009, in order to discuss issues of equity and resource al-
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location of medical performances in a solidly financed health system. Be-
sides theoretical analyses, the main conference foci will cover national and 
international practical examples, interdisciplinary approaches to research 
and HTA-perspectives, which stress different aspects of (in-)equity in health 
care. The conference is open to the public with free admission.  
The conference program is available online at:  
http://hta.lbg.ac.at/media/pdf/FairHealth_LBI_HTA_ENDPROGRAMM.p
df  
Furthermore, the LBI-HTA is planning a publication (book) which shall in-
clude the articles of the conference speakers as well as contributions from 
other outstanding national and international experts dealing with (in-)equity 
issues and resource allocation in the context of health care. 
The seminar series “decision-support in health care" addresses the health 
administration, journalists, academia in health care and the interested gen-
eral public. Five to six presentations per year are offered, with free admis-
sion. Duration: two hours plus discussion. 
Reform pool projects about integrated delivery of health care 
31-01-2008 | 16:00 | LBI-HTA 
Speaker: Mag. Michel Haas, CEO Geniaconsult 
Blood consumption in Austria: Careless handling with a human resource?  
06-03-2008 | 16:00 | LBI-HTA 
Speaker: Prof. Dr. Hans Gombotz, General Hospital Linz (AKH) 
Which medical interventions are innovative?  
10-04-2008 | 16:00 | LBI-HTA 
Speaker: Dr. Fabian Waechter, AGES PharmMed 
Nasty or Nice? A perspective on health technology assessment in the 
United Kingdom  
16-05-2008 | 18:00 | House of the “society for physicians in Vienna“ 
Speaker: Prof. Michael Drummond, University of York 
IQWIG-Methods: Developments for cost benefit analyses  
02-10-2008 | 17:00 | House of the “society for physicians in Vienna“ 
Speaker: PD Dr. Peter Kolominsky-Rabas, Director Health economics of 
IQWIG 
Emerging technology assessment program in Australia 
14-11-2008 | 15:00 | LBI-HTA 
Speaker: Prof. Brendon Kearney, Deputy Chair of MSAc (Australian Gov-
ernment Department of Health and Ageing) 
Limits of oncological treatment: expectations, hopes and reality 
27-11-2008 | 16:00 | LBI-HTA 
Speaker: OA Dr. Johann Zoidl, Executive palliative care, Hospital of the 
Merciful Sisters Linz 
Two or three-times per year advanced training sessions - conducted by spe-
cialists - on methodological questions are offered to the LBI-HTA research-
ers. By invitation external colleagues are also very welcome. 
English used in scientific manuscripts and improving the chances of pub-
lishing by avoiding common mistakes and pitfalls 
13-03-2008 | 15:00-17:00 | LBI-HTA 
Speaker: Tim Skern 
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Equity and ethics related to resource allocation 
27-05-2008 | 15:00-17:00 | LBI-HTA 
Speaker: Dr. Claudia Wild 
Clinical research – Study protocols 
28-10-2008 | 15:00-17:00 | LBI-HTA 
Speaker: Dr. Harald Herkner 
The application of the GRADE tool for evaluating medical interventions of 
the Austrian CAL - catalogue of ambulatory services - Update 
16-12-2008 | 09:00-13:00 | LBI-HTA 
Speaker: Prof. Dr. Gerald Gartlehner, MPH 
ÖGOR Conference “Operations Research in Health Care” 
01-12-2008 | 13:00 | LBI-HTA 
Speakers: Dr. Evrim Gunes (Koc University, Istanbul) & Dr. Michael Gy-
imesi (LBI-HTA) 
The aim of a periodical, electronic-only HTA newsletter is to transfer the re-
sults of international assessments into a German-language, easily readable 
journalistic format: each month four articles on relevant technolo-
gies/interventions are selected. Often, but not always, topics which at least 
two different HTA institutions have worked on and published independently 
are chosen. An editorial article, often written by an invited expert, deals with 
horizontal topics such as methodological aspects or questions of health pol-
icy. The newsletter has been published 10 times per year since May 2006. 
Project leader: Claudia Wild, Gerda Hinterreiter (since 10-2008) 
Duration: 10 x p. a. 
The LBI-HTA website http://hta.lbg.ac.at contains updated announcements 
or presentations of publications and reports, research projects, events, press 
reviews, team profiles and other current news concerning the LBI-HTA.  
Project leader/Webmaster: Gerda Hinterreiter (since 09/2008) 
Horizon scanning in oncology: Concept development of a horizon scan-
ning system in Austria 
Project leader: Sabine Geiger-Gritsch 
Duration:  07/2007 – 05/2008 
Background: The scientific and medical progress in oncology quickly leads 
to the introduction of new medicines. In addition, the development of new 
therapy modalities, the so-called "targeted therapies" such as e.g. monoclonal 
antibodies or tyrosine kinase inhibitors ("small molecules"), results in a 
rapid increase in the medicine costs in oncology in hospitals. The fast and to 
some extent uncontrolled use of these expensive cancer medicines in clinical 
practice, as well as their increasing off-label use, has an effect on hospital 
drug budgets. The development of a "Horizon Scanning System" for the early 
identification and evaluation of new drug therapy concepts in oncology, i.e. 
before a routine introduction to cancer treatment, should purposefully pre-
pare hospitals (respectable drug commissions) for new cancer medicines and 
should contribute to rational decision making as well as supporting the pro-
spective budget planning.  
Research objective: The aim of this project is to design a guideline, firstly for 
the systematic collection of information (sources for identification and crite-
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ria for prioritisation) about new drugs in oncology (incl. existing drugs with 
extension of indication) relevant for hospitals, and secondly, for their early 
evaluation on the basis of defined parameters. 
Methods: Database search; analysis of information sources, criteria for pri-
oritisation and parameters for evaluation. 
Publication: HTA Project Report 14 – http://eprints.hta.lbg.ac.at/798/ 
Horizon Scanning in Oncology - Part II: From pilot to routine 
Project leader: Sabine Geiger-Gritsch 
Duration:  10/2008 – 09/2009 
Background: The establishment of a Horizon Scanning System for antican-
cer drugs is an important tool to prepare Austrian hospitals for new/ emerg-
ing medicines. The first part of our project "Horizon Scanning in Oncology", 
which was carried out between July 2007 and May 2008 focused on the de-
velopment of a concept for a Horizon Scanning System in oncology and the 
testing of two important steps (i.e., "identification" and "prioritisation") in 
the context of a short pilot. On the whole our initial experiences with the 
Horizon Scanning System from the feasibility study were acceptable but sev-
eral changes, especially regarding the collection of data on anticancer drugs 
and the priority setting process, were proposed by the involved experts. 
Aims and research objectives: Based on these findings, the second part of the 
project aims to implement the proposed concept. Therefore, the next steps 
will be to work out an optimised final concept with various stakeholders (e.g. 
hospital administrators, clinical experts, drug commissions), taking into 
consideration the results of the feasibility study. In addition, the Horizon 
Scanning System should be made standard practice at the LBI-HTA to regu-
larly provide Austrian hospitals (hospital management and drug commis-
sions) with information about new/ emerging anticancer drugs to support 
their financial drug budget planning and rational decision making. 
As an input for the international HTA-community, the Ludwig Boltzmann 
Institute for HTA joined the “International Information Network on New 
and Changing Health Technologies” (EuroScan) in November 2008. 
Method: Development of an optimised and final concept of „Horizon Scan-
ning in Oncology“ (Part I: http://eprints.hta.lbg.ac.at/798/) with involve-
ment of several decision makers (e.g. drug commissions), followed by its im-
plementation in standard practice.  
Key factors in implementing, performing and analysing registries for 
cardiovascular, neurological and spine specific questions  
Project leader: Stefan Mathis 
Duration:  06/2007 – 06/2008 
Background: While randomised controlled studies evaluate health technolo-
gies in selected patients, registries cover data from medical interventions in 
real life situations. Registries are expected to contribute additional informa-
tion about clinical but also socio-political aspects. However, it is not clear for 
what kind of questions registries are the adequate methodical approach and 
what are the key factors for implementing, performing and analysing regis-
tries.  
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Aims and research objectives: The aim of this project is to give an overview 
of current registries in cardiovascular, neurological and spine specific fields, 
to analyse the kind of clinical and socio-political questions being addressed, 
and to identify practical and methodical models of best practice as well as 
key factors for implementing meaningful registries. 
Method: Systematic search for registries and adequate methodological litera-
ture; systematic analysis of the registries' objectives. 
Publication: HTA Project Report 11 - http://eprints.hta.lbg.ac.at/788/ 
Procedures in evaluation – kyphoplasty and vertebroplasty 
Project leader: Rosemarie Felder-Puig  
Duration:  2006 – 2009 
Background: Conservative treatment of vertebral compression fractures 
(VCF) in older patients includes bed rest and analgesics followed by mobili-
sation and eventually, the use of a bodice. Alternatively, two minimally inva-
sive procedures – percutaneous kyphoplasty (KP) and vertebroplasty (VP) – 
are available. Patients with osteoporotic VCF and chronic pain in particular 
may benefit from these techniques. VP, which is less costly than KP, induces 
quick pain relief. KP also leads to quick pain reduction. In addition, it is in-
tended to be safer and to restore vertebral height, as well as guaranteeing a 
lower risk of refracture. However, there is insufficient evidence about these 
benefits for patients. In particular, long-term results and cost-effectiveness 
data are scarce.  
Aims and research objectives: A study conducted at the Austrian AUVA hos-
pitals should be able to provide data about the effectiveness of KP and VP 
under real-life conditions. The study will be performed in cooperation with 
other clinics (University Clinics of Orthopaedics at Vienna and Graz, Ha-
nusch Hospital Vienna) and will collect data prospectively for a time inter-
val which has yet to be defined.  
Method: Empirical study, application study; co-ordination of participating 
institutions; production of study documents (protocol, CRF, patient consent 
form, application to Ethics Committee, registration); implementation, data 
entry and analysis; presentation of results and publication. 
Developing a decision aid on HPV-vaccination for young girls and 
women/mothers  
Project leader: Brigitte Piso  
Duration:  09/2008 – 12/2008 
Background: Epidemiological studies show that an infection with human 
papilloma virus (HPV) is a necessary factor in the development of cervical 
carcinoma and its early stages. In addition to the effective cervical screening 
programs (PAP-smear), two vaccines against the two most common cancer-
causing strains of HPV have been licensed. Persuasive advertising by the 
companies does not provide reliable information about the disease, the vac-
cine or possible alternatives for young girls and women.  
Aims and research objectives: To encourage shared decision making, the 
“Developing a decision aid on HPV-vaccination“ project aims to prepare evi-
dence-based online and/or printed information on HPV according to the 
DISCERN criteria (www.discern.com).  
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Methods: A decision aid should be developed on the basis of standardised, 
evidence-based, qualitative analysis on the evidence on decision aids and 
target groups, unsystematic web research, and also of a systematic literature 
review. The project consists of three parts: first of all the content will be ex-
pressed in plain text, suggestions for the graphical conversion will be made 
and the readability and comprehensibility will be tested in an Austrian focus 
group. The subsequent evaluation of the final version is not part of this pro-
ject. If new findings have been made public or complications have occurred, 
the content of the decision aid will be updated after one to two years. 
EUnetHTA – Application studies and surveillance systems in the EU 
Project leader: Rosemarie Felder-Puig  
Duration: 2006 – 2008 
Background: Since the effectiveness and cost-effectiveness of many of the 
health technologies that are introduced in health care systems cannot be 
evaluated before broader application under real-life conditions, many coun-
tries either release technologies that are not fully assessed or require post-
marketing follow-up studies. An alternative is the requirement to monitor 
the use and the outcome of a technology. For this reason, some countries 
have started to set up „registries” or „application protocols” in order to keep 
some health technologies (often surgical or costly interventions) under sur-
veillance before broader diffusion takes place and until decisive evidence is 
available. The objective of Strand A of Work Package 7 of EUnetHTA is to 
provide tools that enable countries to monitor the development of emerging, 
new or established health technologies and to share data and results from 
this monitoring.  
Aims and research objectives: Overview of existing monitoring tools (appli-
cation studies, registries, etc.) within EU25 countries and of technologies 
that are currently being monitored with these tools; development of com-
monly shared monitoring tools that are relevant to the different technologies 
considered and adapted to the resources available in institutions in charge of 
technology assessment.  
Method: Piloting of one monitoring tool and testing the feasibility of pooling 
data from different countries using a common monitoring tool. 
Publications: Available at EUnetHTA/ WP 7 – http://www.eunethta.net/ 
As mentioned in chapter 1.7, the EUnetHTA Project was established in 2006 
following the request of EU Member States in the High Level Group on 
Health Services, endorsed by the Council of Ministers of Health and the 
European Commission, to establish a sustainable network for health tech-
nology assessment (HTA). The Project was co-funded by the European 
Commission for three years and has established an effective European net-
work for HTA that aims to inform policy decisions on the use of health 
technologies at the national or regional level.  
A total of 64 partners (HTA institutions and organisations) from 29 Euro-
pean countries including 21 EU Member States have joined the EUnetHTA 
Project, which is organised as an open network with extensive communica-
tions facilities. EUnetHTA coordinates the efforts in the evaluation of health 
technology in Europe. The general strategic objective of the network is to 
connect public national/regional HTA agencies, research institutions and 
health ministries, enabling an effective exchange of information and support 
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to policy decision-making by the member states. During the first three years 
of existence (2006-2008) EUnetHTA aimed to develop an organisational 
framework for a sustainable European network for HTA along with practical 
tools to use within this framework to ensure timely and effective production, 
dissemination and transfer of HTA results into applicable policy advice for 
the Member States.  
Co-funding from the European Commission for the EUnetHTA Project 
ceased at the end of 2008. The experience of collaboration among partners in 
EUnetHTA is positive, and to ensure that communication, collaboration net-
works and activities are continued, the partners have decided to create a sus-
tainable, permanent European HTA collaboration. This will involve HTA 
Agencies and other producers of HTA information, with support from Euro-
pean governments, the European Commission and international health or-
ganisations. Therefore, on June 16th 2008 the EUnetHTA Steering Commit-
tee endorsed a proposal for a permanent collaboration, called the 
‘EUnetHTA Collaboration’. The mission of this collaboration is to support 
effective HTA collaboration in Europe that brings added value at the Euro-
pean, national and regional level. 
To ensure the continuity of EUnetHTA in the interim period of 2009, a 
group of 25 partner organisations, so-called “founding partners”, from 13 
EU Member States (+Norway and Switzerland) developed a strategic con-
cept with regard to a sustainable coordination of the network and the careful 
involvement of partners in the EU Joint Action on HTA. 
Inno-HTA - HTA-methodology for innovative healthcare technologies 
Project leader: Claudia Wild, Philipp Radlberger  
Duration: 01/2007 – 12/2008 
Background: At the beginning of 2007 DG SANCO commissioned a project 
for assessing (fields of) technologies in the earliest stages of development. 
The project leader is the Fraunhofer Institute for Systems and Innovation 
Research (ISI). Other partner institutions are the University of Luebeck, the 
University of Nottingham, the Danish National Board of Health, Health Sta-
tistics and Medical Technologies State Agency, Latvia, and the GSF - For-
schungszentrum für Umwelt und Gesundheit GmbH, Germany.  
Aims and research objectives: The project is intended to lead to a set of real-
istic indicators. These indicators are seen as a tool for assessing the strengths 
and weaknesses of (fields of) technologies despite the high degree of uncer-
tainty surrounding them. Inno-HTA will attempt to add a broad perspective 
of HTA-relevant aspects and potential actor groups. Questions related to the 
potential for obtaining valid data about the quality of technologies will be 
crucial in choosing the indicators. 
Method: Design of three different case studies, comparison of the results 
with those of three other studies, and the testing of a set of indicators on the 
basis of these examples. 
Publications: Available at Inno-HTA – http://www.inno-hta.eu/ 
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2.2 Publications 
Mad, P., Wild, C., Langer, T., Kvas, E., Guba, B., Reichelt, C., Adlbrecht, C. 
(2008): Rolle und Positionierung der Ambulanzen von Universitätskliniken 
im Gesundheitswesen. Project Report No. 005 
Radlberger, P., Johansson, T., Wild, C. (2008): Ökonomische Aspekte einer 
effektiven und effizienten alkoholtherapeutischen Versorgung; Teil I: Inter-
nationale Versorgungsmodelle und Ansätze für Ergebnismessung. Project 
Report No. 010 
Mathis, S., Wild, C. (2008): Register für klinische und gesundheitsökono-
mische Fragestellungen. Einsatzbereiche von kardiovaskulären, wirbel-
säulenspezifischen und neurologischen Registern und Good Practice Strate-
gien für die Arbeit mit Registern. Project Report No. 011 
Felder-Puig, R., Chwala, E. (2008): Rückenschmerzen. Diagnostik und Be-
handlung nach evidenzbasierten Leitlinien – Möglichkeiten und Grenzen. 
Project Report No. 012 
Falkner, E., Wild, C. (2008): Klinische Anwendung von Tissue Engineering. 
Ein Überblick über internationale und österreichische Forschungsfelder mit 
einer kritischen Analyse selektierter Anwendungen. Project Report No. 013 
Geiger-Gritsch, S. (2008): Horizon Scanning in Oncology. Concept Devel-
opment for the Preparation of a Horizon Scanning System in Austria. Pro-
ject Report No. 014 
Piso, B. (2008): Ambulante Kardiologische Rehabilitation; Teil I - Evalua-
tion und Indikatoren Teil II - Vergleichende Analyse unterschiedlicher Re-
habilitationsmodelle und Phase III. Project Report No. 015 
Mad, P., Johansson, T., Guba, B., Wild, C. (2008): Klinische Pfade. Sys-
tematischer Review zur Ergebnismessung der Wirksamkeit. Project Report 
No. 016 
Felder-Puig, R., Mittermayr, T., Mathis, S. (2008): Klavikulafrakturen. Ein 
systematischer Review zu Wirksamkeit und Sicherheit verschiedener 
Therapiekonzepte. Project Report No. 017 
Zechmeister, I., Stollenwerk, B., Ara, R., Ward, S. (2008): Statins for the 
Secondary Prevention of Cardiovascular Diseases: An Analysis of Expected 
Population Health Gains and Cost-Utility in Austria. Project Report No. 018 
Zechmeister, I., Stollenwerk, B., Langley, T. (2008): Have Statins met our 
Expectations? A Comparison of Expected Health Gains from Statins with 
Epidemiological Trends in Austria. Project Report No. 019  
Breyer, E. (2008): Aktualisierung von Leistungskatalogen. Eine verglei-
chende Analyse von Refundierungsprozessen für ärztliche Leistungen in 
ausgewählten Ländern. Project Report No. 022 
Piso, B., Wild, C. (2008): Rational Vaccination Policies – decision support. 
Review of International Literature for „Rational“ Vaccination Policies. 
Rapid Assessment No. 003 
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Pramesberger, C., Adlbrecht, C., Guba, B., Felder-Puig, R. (2008): Neue 
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No. 016 
Langley, T., Geiger, W., Gartlehner, G. (2008): Bach Flower Remedies for 
pain relief and psychological problems. Systematic review. Decision Support 
Document No. 017 
Wild, C., Langley, T., Guba, B., Gartlehner, G. (2008): Minimal-invasiver 
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hernia as a typical postoperative complication of minimally invasive surgery 
among preschool children. Surg Endosc, 22: 2724-2727 
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Felder-Puig, R., Piso, B., Guba, B., Gartlehner, G.: Kyphoplastie und Verte-
broplastie bei osteoporotischen Wirbelkörperkompressionsfrakturen. Sys-
tematischer Review. Der Orthopäde, submitted in summer 2008, in review 
Geiger-Gritsch, S., Stollenwerk, B., Miksad, R., Guba, B., Wild, C., Siebert, 
U. (2008): Safety of Bevacizumab, an Antibody against Vascular Endothelial 
Growth Factor: A Meta-Analysis of Randomized Controlled Trials in Pa-
tients with Advanced Cancer. Lancet Oncology, submitted in December 
2008 (former rejected from ‚JAMA’ and ‘Archives of Internal Medicine’) 
Mathis, S., Guba, B., Pramesberger, C., Adlbrecht, C.: Systematische Über-
sichtsarbeit: Minimal-invasive Methoden bei Belastungsinkontinenz. Der 
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Piso, B., Mathis, S.: Effektivitätsanalyse der kardiologischen Phase III Re-
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Piso, B., Wild, C.: Decision Support in Vaccination Policies. Vaccine, sub-
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Zechmeister, I., Freiesleben de Blasio, B., Garnett, G.: HPV-vaccination for 
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Zechmeister, I., Freiesleben de Blasio, B., Garnett, G., Neilson, A., Siebert, 
U. Cost-effectiveness analysis of human papillomavirus vaccination pro-
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Felder-Puig, R., Mad, P., Gartlehner, G.: Diagnostische Studien. Wiener 
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Felder-Puig, R., Topf, R., Maderthaner, R., Gadner, H., Formann, A.K.: Das 
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Monatsschrift Kinderheilkunde, in print 
Geiger-Gritsch, S., Piso, B., Guba, B., Felder-Puig, R.: Stentgraftimplanta-
tion bei Erkrankungen der Aorta Ascendens – Eine Systematische Über-
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Wild, C., Langley, T., Guba, B., Gartlehner, G.: Minimal-invasiver perkuta-
ner Aortenklappenersatz. Der Kardiologe, in print 
Wild, C., Simpson, S., Douw K., Geiger-Gritsch, S., Langer, T.: Information 
service on new and emerging technologies – identification and priorisation 
processes for EU-wide newsletter. International Journal of Technology As-
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Wild, C.: Implementierung von HTA in Österreich. Zeitschrift für Evidenz, 
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Wild, C.: Austria: History of HTA since 20 years. International Journal of 
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Zechmeister, I., Mathis, S., Guba, B., Gartlehner, G.: Low-Density Lipopro-
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Übersicht. Medizinische Klinik, accepted 
Zechmeister, I., Radlberger, P.: Gesundheitsökonomische Evaluation. Wie-
ner Medizinische Wochenschrift, accepted  
Zechmeister, I., Freiesleben de Blasio, B., Garnett, G.: HPV-vaccination for 
the prevention of cervical cancer in Austria: A model based long-term prog-
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Winkler, R. (2008): Ethik und Gerechtigkeit in der Medizin. ÖKZ (49), 12  
Zechmeister, I. (2008): HPV-Impfung in Österreich. Biomed Austria. Spring 
2008: 8-9 
non peer-reviewed 
articles  
Annual Report 
2008 
44 LBI-HTA | 2009 
Gyimesi, M. (2008): Simulation Service Providing: Simulationsdienstlei-
stungen auf Basis einer serviceorientierten Architektur. Vdm Verlag Dr. 
Müller 
Hinterreiter, G. (2008): Auswirkungen der Arzt-PatientInnen-Beziehungen 
am Beispiel Cholesterinsenkung - Eine empirische Studie zur Situation in 
Oberösterreich. Gesundheitswissenschaften Band 34, OÖGKK, Linz 
Mathis, S., Torre, M. (2008): Characterising registries from a reviewer’s per-
spective. Technical report. EUPHORIC Project; Final Workshop 11/-
12/12/2008; Istituto Stituto Superiore di Sanità (ISS), Rome 
Wild, C. (2008): Verteilungsgerechtigkeit und Ressourcenallokation: Fokus 
Kindermedizin. In: Politische Kindermedizin: Werte vs. Ökonomie. (Hrsg.) 
Waldhauser, F. Springer Verlag. 35-45 
Zechmeister, I. (2008): Psychische Gesundheit zahlt sich aus!? Evidenz zur 
Wirtschaftlichkeit von ‚Mental Health’ Förderungs- und Präven-
tionsmaßnahmen. In: Meggeneder, O.: Volkswirtschaft und Gesundheit. 
Frankfurt am Main: Mabuse Verlag 
Falkner E., Eder C. (2008): “The HET-CAM Model for Tissue Engineering 
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Felder-Puig, R. (2008): „Counseling – Probleme des ärztlichen Gesprächs“, 
Tagung „Ist Vorsorgen immer besser als Heilen“, Ein Evidenz-basiertes 
Symposium über Gesundheitsförderung und gesundheitliche Prävention. 
Danube University Krems, 20/02/2008 
Felder-Puig, R., Guba, B., Gartlehner, G. (2008): „Evidenzbasierte Bewer-
tung von medizinischen Einzelleistungen in Österreich“, 9. Jahrestagung des 
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Felder-Puig, R. (2008): „Optische Kohärenztomografie bei koronarer 
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Felder-Puig, R. (2008): „Kyphoplastie und Vertebroplastie bei osteoporoti-
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schaftliche Halbjahrestagung der Gesellschaft für Pädiatrische Onkologie 
und Hämatologie. Vienna, 20/11/2008. 
Geiger-Gritsch, S. (2008): “Horizon Scanning in Oncology”, HTAi Confer-
ence, 5th Annual Meeting, Montreal/Canada, 07/07/2008 
Geiger-Gritsch, S. (2008): “Safety of Bevacizumab, an Antibody against Vas-
cular Endothelial Growth Factor: A Meta-Analysis of Randomized Con-
trolled Trials in Patients with Advanced Cancer”, GMDS Tagung, Stutt-
gart/Germany, 16/09/2008 
Geiger-Gritsch, S. (2008): „Horizon Scanning in Oncology“, EuroScan Meet-
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Umsetzungsbeispiele in der österreichischen Sozialversicherung“, Open: 
QM, Graz, 19/05/2008 
Gyimesi, M., Breitenecker, F., Heidl, W., Eitzinger, C. (2008): “Artificial 
Neural Network-Based Classifikation of vector sets for surface inspection”, 
EMSS 2008, 20th European Modeling and Simulation Symposium, Aman-
tea/Italy, 09/2008 
Gyimesi, M. (2008): „Modellbildung und Simulation dynamischer Systeme – 
Anwendungen im österreichischen Gesundheitswesen“, Österreichische Ge-
sellschaft für Operations Research, Vienna, 01/12/2008 
Mad, P. (2008): „Klinische Pfade zur Optimierung der Gesundheitsversor-
gung“, Tagung „Ist vorsorgen immer besser als heilen?“ Ein Evidenz-
basiertes Symposium über Gesundheitsförderung und gesundheitliche Prä-
vention, Danube University Krems, 20/02/2008 
Mad, P. (2008): „Perkutan implantierbare Pulmonalklappen bei angebore-
nen Herzfehlern des rechtsventrikulären Ausflusstraktes“, Vortragsreihe 
„HTA in Krankenanstalten“, LBI-HTA, Vienna, 03/06/2008 
Mad, P. (2008): „UpToDate gezielt verwenden“, Jahrestagung der Öster-
reicheinschen Gesellschaft für Innere Medizin ÖGIM, Vienna, 18/09/2008 
Mathis, S. (2008): „Anwendungsbeobachtung und Register“, HTA teaching 
at the Danube University Krems, 08/05/2008 
Mathis, S. (2008): „Patientenorientierung in Registerprojekten“, 
eHealth2008, Vösendorf, 30/05/2008 
Mathis, S., Mad, P. (2008): “Challenges for register projects: A systematic 
review of good practice strategies for the work with registries”, HTAi Con-
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Mathis, S. (2008): “Characterisation of register projects by using category 
systems”, Final Workshop of the EUPHORIC Project funded by the Euro-
pean Commission, Rome/Italy, 11/12/2008 
Piso, B. (2008): „Rational Vaccination Policies“, Meeting of the Scientific 
Advisory Group of the LBI-HTA, Vienna, 30/04/2008  
Piso, B. (2008): „Rationale Impfpolitiken“, HTA in hospitals, Vienna, 
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Piso, B. (2008): “Rational Vaccination Policies”, HTAi Conference, 5th An-
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Piso, B. (2008): “Rationale Impfpolitiken”, 9. Symposium Health Technolo-
gy Assessment „Patienten im Niemandsland“, Cologne/Germany, 
17/10/2008 
Piso, B. (2008): „Rationale Impfpolitik- eine Entscheidungsunterstützung - 
Ein Stufenmodel zur Impfentscheidung für EntscheidungsträgerInnen, Ärz-
tInnen und PatientInnen“, Veranstaltungsreihe der Österreichischen Gesell-
schaft für Public Health (ÖGPH) und der Ärztekammer für Wien - Aus-
landsbüro (ABW), Vienna, 13/11/2008  
Radlberger, P. (2008): “Alcohol therapy: international good practice strate-
gies and the challenge of standardization”, HTAi Conference, 5th Annual 
Meeting, Montreal/Canada, 08/07/2008 
Wild, C. (2008): „Die Bewertung neuer Methoden in der Medizin“ im Rah-
men des Seminars „Praxisnahe Medizinethik“, Medizinische Gesellschaft 
für OÖ, Linz, 11/01/2008 
Wild, C. (2008): „Health Technology Assessment zur Politikberatung“, Ta-
gung “Ist Vorsorgen immer besser als Heilen“ Ein Evidenz-basiertes Sympo-
sium über Gesundheitsförderung und gesundheitliche Prävention, Danube 
University Krems, 21/02/2008 
Wild, C. (2008): „Impact von HTA in Österreich und Einsatzbereiche“, 
UMIT-Seminar, 29/02/2008 
Wild, C. (2008): „HTA in Österreich und im LBI“, HTA teaching at the 
UMIT, 11/03/2008 
Wild, C. (2008): “Ressourcenallokationsentscheidungen in der Medizin: 
Grund zum Fürchten?“, 10. Jahrestagung der AG Pädiatrische Endokrinolo-
gie und Diabetologie“ Maria Alm, 15/03/2008 
Wild, C. (2008): “Evidence, fairness & access: A broader HTA-perspective – 
Avastin as example”, HTAi Conference, 5th Annual Meeting, Mont-
real/Canada, 08/07/2008 
Wild, C. (2008): „Wirtschaftliche Beurteilung von Arzneimitteln im 
Krankenhaus“, Baxter-Innovationsabend, Vienna, 23/09/2008 
Wild, C. (2008): „Kann der Verzicht auf Impfungen teuer werden? Kosten 
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diskussion, Vienna, 02/10/2008 
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Zechmeister, I. (2008): „Gesundheitsökonomische Evaluation der HPV-
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Österreich“, Tagung der Österreichischen Gesellschaft für Operations Re-
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Zechmeister, I. (2008): “Economic evaluation of a vaccination against the 
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Zechmeister I. Freiesleben de Blasio, B., Garnett, G., Neilson, R., Radlber-
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Falkner, E., Eder, C. (2008): “Serum Free Stem Cell Culture 2008”, Frauen-
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Evaluating the reliability of prognoses for diagnoses derivating the ICD-10 
Code from the ATC-Code”, PCSI 2008 
Mathis, S. (2008): “Patientenorientierung in Registerprojekten”, 
eHealth2008, Vösendorf, 30/05/2008 
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Zechmeister, I., Stollenwerk, B. (2008): “A comparison of expected health 
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liosis Research Society Worldwide Programme on “Spinal Deformity: Cur-
rent Concepts”, New Dehli, 02/-05/10/2008  
Falkner, E. [Coauthor] (2008): “Tissue Engineering from Bench to Bedside 
– Transplantsimulation via HET-CAM Test”, Poster Award of the Society 
for Basic Research (DGOC e.V.) and the German Society for Trauma Sur-
gery, German Congress for Orthopaedics and Trauma Surgery, Berlin,24/-
27/10/2008 
Breyer, E. (2008): Refluxösophagitis: Minimalinvasiver Eingriff vs. Lang-
zeitmedikation. HTA-Newsletter November 2008: 4 
Falkner E., Wild C.: Kognitive Verhaltenstherapien – Depressionen und 
Angststörungen. HTA-Newsletter January 2008: 2 
Falkner E. (2008): Biomarker. HTA-Newsletter March 2008: 3-4 
Falkner E. (2008): Wiederverwendung von Einweg-Medizinprodukten. 
HTA-Newsletter May 2008: 2-3 
Falkner E. (2008): Neue minimal-invasive Methoden bei Belastungsinkonti-
nenz – Einsatz von Stammzellen. HTA-Newsletter June 2008: 3-4 
Falkner E. (2008): Tissue Engineering in der klinischen Praxis. HTA-
Newsletter September 2008: 2 
Felder-Puig, R. (2008): Kyphoplastie & Vertebroplastie bei osteoporotischen 
Wirbelkörperkompressionsfrakturen. HTA-Newsletter June 2008: 2 
Felder-Puig, R. (2008): Nicht-spezifische Rückenschmerzen: Evidenzbasier-
te Diagnostik und Therapie. HTA-Newsletter July/August 2008: 4 
Felder-Puig, R. (2008): Hadrontherapie: Strahlentherapie für seltene Tumo-
re. HTA-Newsletter October 2008: 3 
Gartlehner, G. (2008): Bachblütentherapie: Systematischer Review. HTA-
Newsletter March 2008: 4 
Geiger-Gritsch, S. (2008): Testosteron-Substitution bei Androgendefizit des 
alternden Mannes. HTA-Newsletter April 2008: 2 
Geiger-Gritsch, S. (2008): Stentgraft Implantation bei Erkrankungen der 
Aorta ascendens. HTA-Newsletter June 2008: 2 
Geiger-Gritsch, S. (2008): Horizon Scanning in der Onkologie : Konzept-
entwicklung. HTA-Newsletter July/August 2008: 3 
Hinterreiter, G. (2008): Narbenhernien: Operationstechniken im Vergleich. 
HTA-Newsletter September 2008: 4 
Hinterreiter, G. (2008): Medizinische Selbsttests: Erwartungen und tatsäch-
licher Nutzen. HTA-Newsletter November 2008: 2 
poster awards 
articles published in the 
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Hintringer, K. (2008): Interferone & Natalizumab: Behandlung der multi-
plen Sklerose (MS). HTA-Newsletter November 2008:2 
Langley, T. (2008): Adipositas: Screening zur Früherkennung? HTA-
Newsletter January 2008: 3 
Langley, T. (2008): Aromatherapie: Systematischer Review. HTA-Newsletter 
March 2008: 3 
Mad, P. (2008): Prophylaxe der RSV-Bronchiolitis: Wirksamkeit und Kos-
teneffektivität von Palivizumab (Synagis ®). HTA-Newsletter January 2008: 
1 
Mad, P. (2008): Interventionelle Kardiologie: Perkutan implantierbare Pul-
monalklappen. HTA-Newsletter June 2008: 6 
Mad, P. (2008): Versorgungsforschung: Ergebnismessung und Wirksamkeit 
klinischer Pfade. HTA-Newsletter July/August 2008: 7-8 
Martin, B. (2008): Masern-Mumps-Röteln-Impfung: Ökonomische Analyse. 
HTA-Newsletter February 2008: 2 
Martin, B. (2008):Extrakorporale Stoßwellentherapie: Tennisellbogen, 
Fersensporn und Kalkschulter. HTA-Newsletter February 2008: 3 
Mathis, S. (2008): Register für klinische & gesundheitsökonomische 
Fragestellungen. HTA-Newsletter May 2008: 3 
Mathis, S. (2008): Selektive Zelladsorption bei entzündlichen Darmer-
krankungen. HTA-Newsletter June 2008: 8 
Mathis, S. (2008): Optical Coherence Tomography bei akutem Koronarsyn-
drom. HTA-Newsletter June 2008: 11 
Mathis, S. (2008): Kleinchirurgische Eingriffe in unterschiedlichen „Set-
tings”. HTA-Newsletter October 2008: 4 
Nachtnebel, A. (2008): Bedingte Erstattung als Steuerungsinstrument: Ein 
erfolgversprechendes Konzept zur Evidenzgenerierung. HTA-Newsletter 
November 2008: 1 
Piso, B. (2008): Rationale Impfpolitiken: Verfügbarkeit, Anwendbarkeit und 
Stellenwert von Entscheidungshilfen. HTA-Newsletter February 2008: 1 
Piso, B. (2008): Sleeve-Gastrektomie - Bariatrische Operation gegen morbide 
Adipositas. HTA-Newsletter February 2008: 4 
Piso, B. (2008): Ambulante Kardiologische Rehabilitation: Indikatoren zur 
Evaluation. HTA-Newsletter July/August 2008: 2 
Radlberger, P. (2008): Biomarker in der Alkoholtherapie: Eignung für  am-
bulanten Einsatz. HTA-Newsletter March 2008: 2 
Radlberger, P. (2008): Kardiale Kontraktilitätsmodulation bei Herzinsuf-
fizienz. HTA-Newsletter June2008: 4 
Radlberger, P. (2008): Versorgung bei Alkoholsucht: Ansätze der Program-
mevaluation. HTA-Newsletter September 2008: 3 
Radlberger, P. (2008): Chronic Fatigue Syndrom: Behandlung der Symp-
tome & psychosozialen Ursachen. HTA-Newsletter November 2008: 3 
Schumacher, I. (2008): Adipositas: Verhaltenstherapie. HTA-Newsletter 
September 2008: 2 
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Winkler, R. (2008): Hautkrebsscreening. HTA-Newsletter May 2008: 2 
Winkler, R. (2008): Therapeutische Kommunikation. HTA-Newsletter Oc-
tober 2008: 2 
Wild, C (2008): Verhaltensstörungen: Schulungsprogramme für Eltern. 
HTA-Newsletter January 2008: 2 
Wild, C (2008): Zahnspangen: Mundgesundheit. HTA-Newsletter April 
2008: 4 
Wild, C (2008): DMP-Brustkrebs: Disease-Management Programm. HTA-
Newsletter May 2008: 4 
Wild, C (2008): Bewertung Medizinischer Einzelleistungen für LKF: Eva-
luation von 10 für den MEL-Katalog vorgeschlagenen Leistungen. HTA-
Newsletter June 2008: 1 
Wild, C (2008): Rheopherese® bei altersbedingter Makuladegeneration. 
HTA-Newsletter June 2008: 2 
Wild, C (2008): Perkutaner Aortenklappenersatz bei inoperablen PatientIn-
nen. HTA-Newsletter June 2008: 3 
Auersperg, V., Wild, C (2008): Diskurs: Kliniker mit/gegen HTA - Wissen-
schafterin: ESWT/Extrakorporale Stosswellentherapie als Beispiel. HTA-
Newsletter July/August 2008: 1 
Zechmeister, I. (2008): HPV-Impfung in Österreich. HTA-Newsletter Feb-
ruary 2008: 2 
Zechmeister, I. (2008): Gebärmutterhalskrebs-Früherkennung: Verbesse-
rung der Teilnahme. HTA-Newsletter April 2008: 2 
Zechmeister, I. (2008): Lipidapherese bei Hypercholesterinämie. HTA-
Newsletter June 2008: 3 
Zechmeister, I. (2008): Deutschland: Methoden zur ökonomischen Evalua-
tion. Für und Wider der deutschen Methoden zur Kosten-Nutzen Bewer-
tung. HTA-Newsletter October 2008: 1 
Zechmeister, I. (2008): Halten Statine was sie versprechen? Erwartete und 
tatsächliche Erfolge in Österreich. HTA-Newsletter October 2008: 2-3 
Johansson, T.: COMET Application K-Project (FFG). Application of mod-
ern information and communication technologies (ICT) to an integrated 
care concept for stroke patients. Applicant: Institute of Public Health, 
Paracelsus Medical University, Salzburg 
Johansson, T.: FWF Der Wissenschaftsfond. Application for funding of the 
stand alone project. Integrated Stroke System in the State of Salzburg.  
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2.3 Participation in Scientific Meetings and 
Conferences 
„Gesundheitsökonomie und Finanzierung - Motor oder Hemmschuh?“, 
Donauspital, Vienna, 15/01/2008 (Claudia Wild) 
Nationale Bioethikkommission „Stammzellforschung – Ethische und Recht-
liche Aspekte“, Bundeskanzleramt, Vienna, 17/-18/1/2008 (Claudia Wild) 
World Forum for Spine Research “The Invertebral Disc”, Kyoto/Japan, 23/-
26/01/2008 (Erwin Falkner) 
Ein Evidenz-basiertes Symposium über Gesundheitsförderung und gesund-
heitliche Prävention „Ist Vorsorgen immer besser als Heilen?“, Krems, 20/- 
21/02/2008 (Claudia Wild, Ingrid Zechmeister, Philipp Mad, Rosemarie 
Felder-Puig, Stefan Mathis, Erwin Falkner) 
Tagung der ÖGOR - Österreichischen Gesellschaft für Operations Research, 
Vienna, 22/02/2008 (Ingrid Zechmeister) 
International Conference on the Occasion of Simone de Beauvoir´s 100th 
Birthday “Age/Aging: On Simone de Beauvoir´s `The Coming of Age´”, 
University of Vienna, 22/-23/02/2008 (Erwin Falkner) 
9. Jahrestagung des DNEbM - Deutschen Netzwerks für Evidenzbasierte 
Medizin „Evidenzbasierte Primärversorgung und Pflege“, Witten-Herdecke/ 
Germany, 22/-23/02/2008 (Claudia Wild, Rosemarie Felder-Puig) 
Biotraining 2008 „Home Monitoring Essentials”, Vienna Hilton Plaza, 
12/03/2008 (Erwin Falkner) 
10. Jahrestagung der AG Pädiatrische Endokrinologie und Diabetologie, 
Maria Alm, 15/03/2008 (Claudia Wild) 
“Wieviele Medikamente verträgt der Mensch“, HVB, Vienna 09/04/2008 
(Claudia Wild) 
Seminar des Ludwig Boltzmann Instituts für Traumatologie, Vienna, 
15/04/2008 (Erwin Falkner) 
Business Circle „Konfrontation Gesundheit“, Vienna, 24/-25/04/2008 (Clau-
dia Wild) 
Open: QM, Graz, 19/05/2008 (Michael Gyimesi) 
eHealth2008 „Medical Informatics meets eHealth”, Vösendorf, 29/05/2008 
(Stefan Mathis) 
Vorlesung des Ludwig Boltzmann Clusters für Kardiovaskuläre Forschung 
“Cardiovascular Tissue Engineering”, General hospital (AKH) Vienna, 
09/06/2008 (Erwin Falkner) 
AETMIS - Agence d’évaluation des technologies et des modes d’intervention 
en santé, “Conditional coverage”, Montreal/Canada, 10/06/2008 (Claudia 
Wild) 
WINEG – Wissenschaftliches Institut der TK für Nutzen und Effizienz im 
Gesundheitswesen, Symposium „Kosten-Nutzen Bewertung“, Ber-
lin/Germany, 17/06/2008 (Claudia Wild) 
Fachtagung „Gesellschaftsbezogene Forschung – Relevanz und Qualität des 
außeruniversitären Sektors“, Vienna, 19/06/2008 (Roman Winkler) 
conferences and 
congresses 
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„(Un)gleich? – Gesundheitliche Versorgung und Gesundheitsförderung – ei-
ne Frage der sozialen Gerechtigkeit?“, Linz, 24/06/2008 (Roman Winkler) 
HTAi – Health Technology Assessment International, 5th Annual Meeting, 
Montreal/Canada, 05/-09/07/2008 (Brigitte Piso, Claudia Wild, Ingrid 
Zechmeister, Philipp Mad, Philipp Radlberger, Roman Winkler, Sabine 
Geiger-Gritsch, Smiljana Blagojevic, Stefan Mathis) 
ECHE – European Conference on Health Economics, Rome/Italy, 23/-
26/07/2008 (Ingrid Zechmeister) 
Patientenentscheidungen, Frankfurt/Germany, 09/09/2008 (Claudia Wild) 
11. Wissenschaftliche Tagung der Österreichische Gesellschaft für Public 
Health, Johannes Kepler University Linz, 11/09/2008 (Claudia Wild, Gerda 
Hinterreiter) 
GMDS Tagung, Stuttgart/Germany, 15/-18/09/2008 (Sabine Geiger-Gritsch) 
Jahrestagung der ÖGIM – Österreichischen Gesellschaft für Innere Medizin, 
Vienna, 18/09/2008 (Philipp Mad) 
„Transparenz und Beteiligung von Patienten im Gesundheitswesen?!“, HVB, 
Vienna, 23/09/2008 (Claudia Wild) 
EMSS 2008 – 20th European Modeling and Simulation Symposium, Aman-
tea/Italy, 09/2008 (Michael Gyimesi) 
European Health Forum Gastein “Values in Health – From Visions to Real-
ity”, Bad Hofgastein, 01/-03/10/2008 (Roman Winkler, Tim Johansson) 
Tagung „Entscheidungen in der Psychiatrie“, UMIT, Hall in Tirol, 03/-
05/10/2008 (Sabine Geiger-Gritsch) 
EAAT Conference 2008 – Annual Meeting of the European Association for 
Addiction Treatment, Florence/Italy, 13/-14/10/2008 (Philipp Radlberger) 
Konferenz des IIR - Institute for International Research, NH Danube City, 
Vienna, 13/-14/10/2008 (Erwin Falkner) 
Auftaktveranstaltung „Armutsminderung durch Menschenrechtsansatz? Eu-
ropäische und globale Perspektive“ der Austrian Development Agency 
(ADA) in der Reihe “DialogEntwicklung", Vienna, 15/10/2008 (Ingrid 
Zechmeister) 
7. Deutscher Kongress für Versorgungsforschung „Innovationstransfer: Von 
der Forschung zum Patienten“, Cologne/Germany, 16/10/2008 (Stefan Mat-
his) 
9. Symposium Health Technology Assessment „Patienten im Niemands-
land“, Cologne/Germany, 17/10/2008 (Brigitte Piso, Rosemarie Felder-Puig) 
EBM-Days, HVB, Vienna, 23/-24/10/2008 (Claudia Wild, Ingrid Zechmei-
ster) 
Linzer Forum 08 „Gesundheit und Gesellschaftspolitik“, General Hospital 
Linz (AKH), 23/10/2008 (Gerda Hinterreiter, Roman Winkler) 
Puls 2008 „Spannungsfeld Versorgungsauftrag und Wirtschaftlichkeit. Ko-
operationen im Gesundheitswesen – Wie extra- und intramuraler Bereich 
profitieren“, Vienna, 23/10/2008 (Stefan Mathis) 
Politische Kindermedizin „Chronisch arm, chronisch krank?“, Salzburg, 
24/-25/10/2008 (Roman Winkler) 
Research 
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Frauenhofer Life Science Symposium “Ischemia and Regeneration”, Leip-
zig/Germany, 24/-25/10/2008 (Erwin Falkner) 
„Soziale Lage – Gender – Gesundheit“, BM für Soziales, Vienna, 28/10/2008 
(Roman Winkler) 
EUPHA Conference 2008 - 16th Annual Meeting of the European Public 
Health Association „I-Health: health and innovation in Europe“, Lis-
bon/Portugal, 04/-08/11/2008 (Brigitte Piso, Claudia Wild, Philipp Radl-
berger) 
3. Wiener Symposium Integrierter Versorgung „Gesteigerte Qualität durch 
Integrierte Versorgung – Realität oder Mythos?“, Vienna, 06/11/2008 (Ro-
semarie Felder-Puig) 
BoneTec 2008, Hanover/Germany, 07/-09/11/2008 (Erwin Falkner) 
ISPOR Conference 2008 - 11th Annual European Meeting, Athens/Greek, 
08/-11/11/2008 (Sabine Geiger-Gritsch) 
„Verletzte Kinderseele“, HVB, Vienna, 12/11/2008 (Roman Winkler) 
Vortrag der Österreichischen Gesellschaft für Public Health (ÖGPH) und 
der Ärztekammer für Wien „Rationale Impfpolitik- eine Entscheidungsun-
terstützung - Ein Stufenmodel zur Impfentscheidung für Entscheidungsträ-
gerInnen, ÄrztInnen und PatientInnen“ (von Brigitte Piso), Vienna, 
13/11/2008 (Erwin Falkner, Gerda Hinterreiter) 
10. Tagung der Österreichischen Gesellschaft für Neuropsychopharmakolo-
gie und Biologische Psychiatrie, Vienna, 20/-21/11/2008 (Roman Winkler) 
EUnetHTA Abschlusskonferenz „HTA’s Future in Europe“, Paris/France, 
20/11/2008 (Claudia Wild, Gerda Hinterreiter, Philipp Radlberger) 
SciCom 08 – Möglichkeiten und Grenzen der Wissenschaftskommunikation, 
Internationale Fachtagung, Technical University of Vienna, 21/-22/11/2008 
(Gerda Hinterreiter) 
AOSPINE Network Symposium “The Intervertebral Disc – From Basic Sci-
ence to Clinical Application”, University of Zurich/Switzerland, 22/11/2008 
(Erwin Falkner) 
Tagung der ÖGOR - Österreichischen Gesellschaft für Operations Research, 
Vienna, 01/12/2008 (Michael Gyimesi, Stefan Mathis) 
HPV – ExpertInnentagung, Hanover/Germany, 09/12/2008 (Brigitte Piso) 
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3 Scientific Cooperation 
EUnetHTA, WP1 Meeting, Paris/France, 17/-18/04/2008 (Claudia Wild) 
EUnetHTA, WP1 Executive Meeting, Copenhagen/Denmark, 29/04/2008 
(Claudia Wild) 
EUnetHTA Final Conference „HTA’s Future in Europe“, Paris/France, 
20/11/2008 (Claudia Wild, Gerda Hinterreiter, Philipp Radlberger) 
EuroScan Meeting, Zurich/Switzerland, 17/-18/11/2008 (Sabine Geiger-
Gritsch, Projekt Horizon Scanning in Oncology) 
Inno-HTA Workshop, Karlsruhe/Germany, 18/-19/06/2008 (Claudia Wild)  
Inno-HTA Final Conference, Copenhagen/Denmark, 03/-04/10/2008 (Clau-
dia Wild) 
EUPHORIC - European Public Health Outcome Research and Indicators 
Collection, 5th Meeting, Innsbruck, 26/03/2008 (Stefan Mathis) 
EUPHORIC Final Workshop, Rome/Italy, 11/12/2008 (Stefan Mathis) 
DNEbM Working Group Meeting „Ethik und Evidenz-basierte Medizin“, 
Network Ethics and EBM, Berlin/Germany, 13/11/2008 (Claudia Wild, Ro-
man Winkler) 
Preparation of the MEL/NUB cooperation with the Medical Service of the 
Central Association of Health Insurance Funds (MDS), Dr. Annette Busley, 
Germany (Claudia Wild)  
Network Ethik und EBM, „Ethik und Evidenz-basierte Medizin“, Ber-
lin/Germany, 13/11/2008 (Claudia Wild, Roman Winkler) 
Organisation and realisation of an international expert-DELPHI on rational 
vaccination policies, 03/-07/2008 (Brigitte Piso) 
Private University for Health Sciences, Medical Informatics and Technology 
(UMIT) - Institute of Public Health, Medical Decision Making and HTA: 
organisation and preparation of the network meeting (methodical and func-
tional exchange), Ebensee, 29/-30/09/2008  
Institute for Epidemiology at the TILAK Ges.m.b.H. (within the „registry 
project”, Stefan Mathis) 
Dr. Gerold Labek, European Arthroplasty Register Coordinator EFORT at the 
Medical University of Innsbruck (within the „registry project”, Stefan Mathis) 
AGES PharmMed, cooperation with Dr. Eberl and Dr. Pilacek in the field of 
quality assurance and tissue repositories; as well as with Dr. Fabian Waechter 
who gave the speech „Which medical interventions are innovative?” on April 
10, 2008 at the LBI-HTA. 
Federal Council of Swizerland, Prof. Slembeck, catalogue of outpatient medical 
care (KAL)  
Cooperations with ScHARR (School of Health and Related Research), the Uni-
versity of Sheffield, the Institute for Public Health, Medical Decision Making and 
EUnetHTA  
cooperation meetings 
EuroScan meeting 
Inno-HTA 
cooperation meetings 
EUPHORIC  
cooperation meetings 
other  
cooperation or  
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other international  
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HTA/ UMIT, and with the “Drahtwarenhandlung- Simulation Services' for adapt-
ing a decision analysis model for evaluating the impact of statin therapy on ac-
tual hospital interventions in Austria (Ingrid Zechmeister) 
Zechmeister, I., Freiesleben de Blasio, B., Garnett, G. (2008): HPV-
vaccination for the prevention of cervical cancer in Austria: A model based 
long-term prognosis on cancer epidemiology. Submitted to the ‘Journal of 
Public Health’ in August 2008: Cooperation with the University of Oslo and 
Imperial College London 
Zechmeister, I, Freiesleben de Blasio, B., Garnett, G., Neilson, A., Siebert, 
U. (2008): Cost-effectiveness of human papillomavirus vaccination programs 
to prevent cervical cancer in Austria. Submitted to the journal 'Value in 
Health’ in November 2008: Cooperation with the University of Oslo, Norwe-
gian Centre for the Health Service, Imperial College London and UMIT 
(Private University for Health Sciences, Medical Informatics and Technol-
ogy) 
In 2008, the following authors contributed to the HTA newsletter in the 
form of an editorial: 
b Univ.-Prof. Dr. Franz Waldhauser, Paediatric clinic, General Hos-
pital Vienna (AKH) 
b Univ.-Prof. Dr. Hans Gombotz & Dr. Axel Hofmann, Dept. for an-
aesthesiology and intensive care, General Hospital Linz (AKH) 
b Dr. Wolfgang Schimetta, Johannes Kepler University Linz 
b Dr. Christina Lammer, Medical sociologist and artist 
b Dr. Vinzenz Auersperg, GfO 
b Mag. Andrea Fried, ÖKZ/ Austrian hospital newspaper, Transpar-
ency International – Austrian Chapter 
b Dr. Ansgar Gerhardus, M.A., MPH, University of Bielefeld 
Residence at the Institute of Public Health, Medical Decision Making and 
HTA at the Private University for Health Sciences, Medical Informatics and 
Technology (UMIT) in line with a cooperation for the development of a de-
cision analytic model in the treatment with statins. Models for the treatment 
with statins in Austria, 31/03/-03/04/2008 (Ingrid Zechmeister). 
 
Residence at the Health Technology Assessment Group/University of Aber-
deen for the purpose of exchanging efficient information management meth-
ods (literature search), 20/-24/10/2008 (Tarquin Mittermayr). 
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4 Other Activities 
Since 2007 Claudia Wild has been a lecturer for the postgraduate course 
“Master of Management in Health Care” at the Danube-University Krems. 
Besides leading a workshop on HTA (05/-10/05/2008), she also gave a lec-
ture on “HTA in health care management“ there (21/06/2008). Claudia Wild 
taught at the Institute of Public Health, Medical Decision Making and HTA 
at the Private University for Health Sciences, Medical Informatics and 
Technology (UMIT) in Hall/Tirol, on March 11 2008. She held a course on 
„Pharmaceutical economics” at the University of Vienna on June 6 2008. 
During the social medicine HTA days she lectured in Linz (30/05/2008), as 
well as in Dornbirn (07/06/2008). 
Ingrid Zechmeister is an assistant lecturer for the Masters’ Course for Pub-
lic Health at the Medical University of Graz; she has also taught in Graz 
(16/05/2008) and in Dornbirn (22/-23/05/2008). Additionally she gave a lec-
ture on “Economic evaluation in health care” both at the Danube-University 
Krems (09/05/ 2008) and at the University of Applied Sciences in Krems 
(17/-18/10/2008). 
Within the context of a HTA workshop at the Danube-University Krems, 
Stefan Mathis gave a visiting lecture on „Observational studies and regis-
tries“ (08/05/2008). 
In 2008 Claudia Wild reviewed manuscripts for the „European Journal of 
Public Health“ as well as the “German Journal for Evidence and Quality in 
Healthcare“ (ZEFQ). Furthermore, she was requested to provide external 
expert opinion for the project „Correct eating from the very first time“ (pro-
ject cooperation between HVB, BMGFJ and AGES). 
In 2008 Ingrid Zechmeister carried out review activity for the project „The 
Netherlands Organisation for Health Research and Development“. 
The following diploma and doctoral theses were supervised by senior re-
searchers, and supported by library services in 2008:  
b Marc Krenn (Alpen-Adria-University Klagenfurt): Telemonitoring 
for cardiovascular diseases – Claudia Wild 
b Mag. Petra Petz (Postgraduate course at the University of Graz, In-
stitute for Social Medicine): Recombinant growth hormone - Clau-
dia Wild 
b Michael Pohl (Master’s course for Public Health at the Medical 
University of Graz): Economic evaluation of health promotion 
measures – Ingrid Zechmeister 
Because the LBI-HTA intends to enable long-term and free access to its pub-
lications, strong emphasis has been placed on the (further) development of 
the document server (http://eprints.hta.lbg.ac.at) which provides extensive 
search options in English and German. 
In addition to this channel of distribution, which is important for the trans-
fer of knowledge, the delivery of publications to the Library of the Medical 
University of Vienna and the legal deposit of copies ensure that scientists 
and students in Austria become familiar with the Institute’s publications. In 
teaching 
expert & referee 
activities 
supervision of diploma 
and doctoral theses 
library information 
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order to raise awareness of the Institute’s research results internationally, 
summaries and other relevant information are regularly sent to the INAHTA 
office. Due to this cooperation, project reports and rapid assessments from 
the LBI-HTA have also been accepted into the HTA-Database of the Centre 
for Reviews and Dissemination in York, and are accessible via 
http://www.crd.york.ac.uk/crdweb/. 
Since September 2008 Tarquin Mittermayr has been in charge of the library 
and supports the LBI-HTA’s scientific staff in the field of literature re-
search.  
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5 Prospects 
There are various challenges for 2009: 
On the one hand the growth of the institute (16 LBI-HTA team members 
and many external experts), the result of third party funded projects and 
rapid policy advising (reports), needs to be managed while maintaining high 
quality standards of research. A change in the structure of the organisation is 
therefore being considered. 
On the other hand, methods to evaluate individual medical services (MEL) 
for the DRG catalogue which were developed in 2007 will now ( 2009) be 
field-tested in cooperation with the German equivalent - “NUB/ New diag-
nosis and treatment procedures”. Transparent and comprehensible process-
ing of data, assessments based on the GRADE tool, as well as (from January 
2009) extraction tables written exclusively in English, all attract a great deal 
of international attention. As far as „globalisation of evidence, localisation of 
decision-making“ is concerned, these methods help to reduce duplication in 
HTA work in the EU. Further cooperation with other EUnetHTA partner 
organisations is planned. 
In May 2009, after three years of operational activity, the LBI-HTA will be 
evaluated, and a decision made with regard to its continuation until 2013. 
International experts will appraise the institute’s work on the basis of ex-
plicit evaluation criteria predefined by the Ludwig Boltzmann Society. Dur-
ing this two-day on-site visit, there will be several discussions with team 
members as well as with institutional partners, and also with the Scientific 
Advisory Group of the LBI-HTA. 
management  
of growth 
avoidance of 
redundancies  
evaluation for  
LBI-HTA’s continuity 
